Professional Documents
Culture Documents
Tata Steel Future Projections
Tata Steel Future Projections
India
Sensex
18,274
Nifty
Contents
0.5
(3.1) (10.5)
Global/Regional indices
Dow Jones
Results
5,481
12,227
(0.3)
3.7
9.1
2,804
(0.5)
1.8
11.6
Nasdaq Composite
FTSE
6,037
(0.4)
0.6
3.7
Nikkie
10,782
0.3
2.7
10.1
IVRCL Infrastructures: Revenue and EBITDA gains nullified by interest cost and
depreciation
Hang Seng
22,900
KOSPI
2,009
5.8
Cash (NSE+BSE)
171
Derivatives (NSE)
1,507
2,105 1,429
163
82
1,547
1,524 1,716
News Round-up
` India's textile, pharmaceuticals & services sectors could expect greater market
openings & automobile parts companies may face stiffer competition after the
country signs a trade agreement with Japan. (ECNT)
` Oil PSUs to hike jet fuel price 4.1% in metros. Oil marketing companies will hike
prices by an average of INR 2,204.48 a kilo litre. (THBL)
Forex/money market
Change, basis points
15-Feb 1-day
Rs/US$
10yr govt bond, %
1-mo
3-mo
45.5
29
8.1
(2)
(12)
` Oil minister S Jaipal Reddy indicated that the govt. may not be able to clear Cairn
Energy Plc's move to sell control in its Indian arm to Vedanta Resources without
meeting state run ONGC's (ONGC IN) demand for an equitable royalty regime in the
Barmer oilfields that account for 90% of Cairn India's (CAIR IN) valuations. (TTOI)
14-Feb
MTD CYTD
FIIs
50
(369) (1,756)
MFs
56
100
(282)
` Kishore Biyani is spinning off his consumer durables business, Ezone, into a separate
entity in order to maximize value from it. The promoter of Pantaloon Retail (PF IN) is
likely to induct strategic investors in 3 months. (ECNT)
` Reliance Industries Ltd (RIL IN) is now going after the tablet PC market, presently
dominated by Apple and Samsung at the premium end. (BSTD)
` GMR Infrastructures (GMRI IN) has raised around USD 113 mn of debt from India
Infrastructure Finance Company Ltd for modernizing Delhi International Airport.
(BSTD)
` Tata Motors (TTMT IN) said it was redrawing distribution plans of its joint venture
with Fiat as sales number of the Italian car maker had not been up to expectations.
Tata Motors global sales up 16% in January. (BSTD)
` TCS (TCS IN) expects to make its fully-integrated information technology solution for
small and medium enterprises, iON, a 1 bn on business in five years. TCS has already
signed up over 130 clients for iON and plans to take the customer base to 1,000 in a
year. (BSTD)
` Jindal Steel and Power Ltd (JSP IN) gets conditional green nod for Orissa plant. (THBL)
` Venus Remedies Ltd (VNR IN) announced the launch of its super speciality oncology
segment 'Passion Oncobiz', entailing an investment of USD 2 mn. (THBL)
` HCL Technologies (HCLT IN) sets up Global Enterprise Mobility lab in Singapore.
(THBL)
Source: ECNT= Economic Times, BSTD = Business Standard, FNLE = Financial Express, THBL = Business Line.
For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES.
REFER TO THE END OF THIS MATERIAL.
Change, %
Best performers
15-Feb 1-day
1-mo
3-mo
HCLT IN Equity
483.0
0.2
2.6
23.1
BHARTI IN Equity
329.2
0.5
(4.2)
5.0
NACL IN Equity
405.2
1.9
6.2
4.7
TCS IN Equity
1097.7
(1.3)
(2.0)
4.7
INFO IN Equity
3106.6
2.2
(3.1)
4.6
UT IN Equity
35.0
(3.6)
(39.2)
(53.0)
IVRC IN Equity
72.9
1.3
(33.7)
(45.1)
Worst performers
PUNJ IN Equity
72.5
(1.0)
(27.6)
(39.2)
IBREL IN Equity
115.3
(1.7)
(5.2)
(38.3)
RCOM IN Equity
101.6
4.4
(26.7)
(37.1)
BUY
Solid operational performance. Tata Steels standalone and consolidated EBITDA was
1.7% and 7% ahead of our estimate. However, below EBITDA line items such as high
tax provision and loss on impairment of assets led to net income miss. Corus
performance, on expected lines, was extremely weak. Tata Steel can deliver significant
earnings growth and stock performance over the next two years from cost-push based
steel price increase, growth from India brownfield expansion and overseas raw material
projects. We reinstate coverage with a BUY rating and end-FY2012E TP of Rs710.
Company data and valuation summary
Tata Steel
Stock data
52-week range (Rs) (high,low)
739-449
Market Cap. (Rs bn)
589.6
Shareholding pattern (%)
Promoters
32.5
FIIs
17.0
MFs
3.7
Price performance (%)
1M
3M
12M
Absolute
(0.9)
(0.3)
14.2
Rel. to BSE-30
2.2
10.8
0.2
Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)
2010
2011E 2012E
(3.3)
64.4
69.7
(103.6) (2,051.8)
8.2
(186.8)
9.6
8.8
1,023.9 1,128.4 1,204.5
(3.3)
65.3
70.6
80.4
153.8 175.4
13.2
6.7
5.8
(1.5)
22.4
18.4
1.1
1.2
0.0
For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
Tata Steel
Tata Steel
Exhibit 1: Tata Steel, Change in estimates, March fiscal year-ends, 2011-13E (Rs mn)
2011E
Earnings (consolidated)
Net sales
EBITDA
Adj. PAT
EPS (Rs)
Volumes
India (mn tons)
International operations (mn tons)
Pricing
HRC price India (US$/ton)
Realization (US$/ton)
Revised estimates
2012E
2013E
2011E
Old estimates
2012E
2013E
2011E
% change
2012E
2013E
1,128,398
153,843
65,270
64.4
1,204,467
175,421
70,606
69.7
1,232,243
202,586
88,655
87.5
1,149,759
156,206
63,411
66.3
1,181,781
175,766
71,290
74.5
1,224,905
201,721
87,106
91.1
(1.9)
(1.5)
2.9
(2.9)
1.9
(0.2)
(1.0)
(6.5)
0.6
0.4
1.8
(3.9)
6.4
14.4
6.9
14.7
9.0
14.8
6.5
14.8
7.1
14.9
9.0
15.1
(1.7)
(2.4)
(2.8)
(1.6)
(2.3)
728
1,110
756
1,142
744
1,117
728
1,085
743
1,100
738
1,067
2.3
1.7
3.8
0.7
4.7
Tata Steel
Exhibit 2: Interim results of Tata Steel (standalone), March fiscal year-ends (Rs mn)
Net sales
Expenditure
Consumption of raw materials
Staff Cost
Power and fuel
Freight and handling
Other Expenditure
EBITDA
OPM (%)
Other income
Interest
Depreciation
Pretax profits
Extraordinaries
Tax
Net income
Ratios
EBITDA margin (%)
ETR (%)
EPS (Rs)
Segment revenue
Steel business
Others
Segment EBIT
Steel business
Others
Margins
Steel business
Others
3QFY11E
0.7
0.2
7.9
(12.7)
(4.8)
9.8
(3.3)
1.7
(% chg.)
3QFY10
16.0
8.5
15.4
(8.2)
13.9
10.8
7.0
30.8
2QFY11
4.1
2.2
12.5
(12.5)
(4.5)
10.2
(2.1)
7.3
(82.0)
(4.0)
(0.3)
0.4
26.6
(8.3)
(95.7)
(19.3)
9.2
26.8
26.5
27.0
(98.5)
(2.1)
1.7
(19.3)
3.6
(26.7)
64,971
4,488
16
8
4
(2)
20,141
163
21,764
43
14
5
6
297
34.5
21.7
33.5
32.9
(1.6)
32.9
1.4
(12.3)
3QFY11
73,974
(45,768)
(17,586)
(5,985)
(3,454)
(3,968)
(14,775)
28,205
38.1
113
(3,354)
(2,864)
22,100
(6,966)
15,135
3QFY11E
73,423
(45,683)
(16,301)
(6,859)
(3,626)
(3,614)
(15,282)
27,741
37.8
630
(3,493)
(2,871)
22,006
(5,502)
16,505
3QFY10
63,749
(42,180)
(15,241)
(6,523)
(3,032)
(3,581)
(13,803)
21,569
33.8
2,636
(4,157)
(2,622)
17,426
(5,508)
11,918
2QFY11
71,068
(44,777)
(15,637)
(6,837)
(3,615)
(3,603)
(15,086)
26,290
37.0
7,327
(3,425)
(2,815)
27,378
(6,726)
20,651
38.1
31.5
15.3
37.8
25.0
17.8
33.8
31.6
12.1
37.0
24.6
20.9
67,731
4,418
58,325
4,100
23,015
172
34.0
28.9
Tata Steel
Exhibit 3: Interim results of Tata Steel (consolidated), March fiscal year-ends (Rs mn)
Net sales
Expenditure
Consumption of raw materials
Staff Cost
Power and fuel
Freight and handling
Other Expenditure
EBITDA
OPM (%)
Other income
Interest
Depreciation
Pretax profits
Extraordinaries
Tax
Net income
Minority interest
Share of profit from associates
PAT after minority interest
Adjusted PAT
Income tax rate (%)
Ratios
EBITDA margin (%)
ETR (%)
EPS (Rs)
Segment revenue
Steel business
Others
Segment EBIT
Steel business
Others
Segment capital employed
Steel business
Others
Margins
Steel business
Others
3QFY11
290,895
(256,648)
(138,887)
(36,087)
(10,314)
(15,935)
(55,426)
34,246
11.8
(1,043)
(7,432)
(11,264)
14,506
1,223
(6,240)
9,489
161
380
10,030
8,266
39.7
3QFY11E
271,006
(238,986)
(120,191)
(35,862)
(9,609)
(14,009)
(59,314)
32,020
11.8
714
(6,969)
(10,889)
14,876
(4,909)
9,967
103
3
10,072
9,967
33.0
3QFY10
262,020
(232,514)
(104,828)
(41,999)
(10,845)
(14,451)
(60,393)
29,506
11.3
4,099
(7,630)
(11,547)
14,428
(1,957)
(8,148)
4,323
(148)
551
4,726
6,280
65.3
2QFY11
286,462
(249,739)
(124,064)
(38,275)
(9,967)
(14,676)
(62,757)
36,723
12.8
8,143
(6,637)
(10,781)
27,448
(316)
(7,450)
19,682
103
3
19,788
19,998
27.5
11.8
39.7
10.5
11.8
33.0
10.5
11.3
65.3
4.8
12.8
27.5
20.7
275,784
32,357
278,086
26,020
273,067
30,067
21,651
2,036
22,655
3,636
560,932
51,757
7.9
6.3
3QFY11E
7.3
7.4
15.6
0.6
7.3
13.7
(6.6)
7.0
(246.2)
6.6
3.4
(2.5)
27.1
(4.8)
56.9
NM
(0.4)
(17.1)
(% chg.)
3QFY10
2QFY11
11.0
1.5
10.4
2.8
32.5
11.9
(14.1)
(5.7)
(4.9)
3.5
10.3
8.6
(8.2)
(11.7)
16.1
(6.7)
(125.5)
(2.6)
(2.4)
0.5
(162.5)
(23.4)
119.5
(209.1)
(31.0)
112.2
31.6
(112.8)
12.0
4.5
(47.1)
(487.3)
(16.2)
(51.8)
56.9
NM
(49.3)
(58.7)
(0.8)
24.4
1.0
7.6
31,391
2,340
(4.4)
(44.0)
(31.0)
(13.0)
515,096
40,055
535,477
48,788
8.9
29.2
4.8
6.1
8.1
14.0
11.5
7.8
(3.6)
(55.0)
(31.7)
(19.2)
Tata Steel
Exhibit 4: Tata Steel, Quarterly analysis of cost-structure, March fiscal year-ends (US$/ton)
3Q 2009
4Q 2009
1Q 2010
2Q 2010
3Q 2010
4Q 2010
1Q 2011
2Q 2011
3Q 2011
855
246
672
147
752
228
737
239
783
270
864
342
940
387
842
282
918
312
906
204
109
50
50
222
270
723
299
74
32
41
122
155
803
232
73
47
46
162
243
798
202
74
42
44
173
264
847
205
88
41
48
185
280
927
160
87
43
48
201
387
1,014
151
91
56
55
217
444
912
203
89
47
47
196
332
993
238
81
47
54
200
372
1,130
81
117
878
(40)
(12)
917
(37)
(3)
901
(22)
16
961
78
104
1,003
118
136
1,068
119
155
1,010
116
126
1,083
85
133
1,116
616
150
49
47
158
97
891
514
130
38
44
164
1
901
460
153
37
45
207
(1)
846
395
145
34
49
211
12
906
362
145
37
50
209
102
942
361
135
34
51
199
163
985
375
137
35
57
220
161
1,059
459
142
37
54
232
136
1,142
545
142
40
63
218
134
Exhibit 5: Tata Steel, valuation, March fiscal year-ends, 2012E basis (Rs mn)
EBITDA
Multiple
(Rs mn)
(X)
Enterprise value
EV
(Rs mn)
(Rs/share)
122,600
6.5
799,353
789
44,473
5.5
244,601
241
6,515
5.5
35,834
35
1,079,788
1,066
400,056
Total borrowings
400,056
395
679,732
671
39,530
39
719,262
710
710
Tata Steel
Exhibit 6: China import iron-ore fines from India (China CFR) prices (US$/ton)
250
200
150
100
50
Feb-11
Oct-10
Jun-10
Feb-10
Oct-09
Jun-09
Feb-09
Oct-08
Jun-08
Feb-08
Oct-07
Jun-07
Feb-07
Oct-06
Jun-06
Feb-06
Oct-05
Feb-05
Jun-05
Exhibit 7: Tata Steel, Key assumptions, March fiscal year-ends, FY2008-2013E (Rs mn)
2008
2009
2010
2011E
2012E
2013E
705
4.8
394
749
5.2
380
635
6.2
307
728
6.4
389
756
6.9
391
744
9.0
355
1,034
22.8
88
1,254
19.0
103
981
14.2
(20)
1,070
14.4
58
1,060
14.7
67
1,055
14.8
77
42.5
46.0
47.3
45.6
45.5
44.0
Tata Steel
Exhibit 8: Tata Steel (standalone), Profit model, balance sheet and cash flow model, March fiscal year-ends, 2008-2013E (Rs mn)
2008
2009
2010
2011E
2012E
2013E
196,910
80,138
2,428
(7,865)
(8,346)
66,355
4,309
(23,793)
46,870
47.5
243,157
91,334
3,083
(11,527)
(9,734)
73,156
(21,139)
52,017
52.7
250,220
89,521
8,538
(15,084)
(10,832)
72,143
(21,675)
50,468
51.2
289,175
113,490
8,664
(13,428)
(11,475)
97,251
20,700
(28,308)
89,643
72.9
318,985
122,600
2,865
(12,930)
(13,490)
99,046
(29,714)
69,332
68.4
382,533
141,098
2,865
(10,448)
(17,616)
115,900
(34,770)
81,130
80.1
218,282
6,818
234,942
78,401
538,443
82,561
43,675
41,032
4,650
364,974
1,551
538,443
242,319
5,857
324,188
100,077
672,441
109,945
34,877
423,718
15,906
86,945
1,051
672,442
371,688
8,677
252,392
99,568
732,324
121,624
38,436
449,797
32,341
90,126
732,324
503,046
9,856
237,392
86,690
836,984
125,149
98,436
449,097
59,500
104,802
836,984
563,286
10,847
207,392
93,200
874,724
166,660
98,436
449,097
48,824
111,708
874,724
635,323
12,006
177,392
104,947
929,668
284,044
8,436
449,097
67,210
120,880
929,668
60,778
1,764
(23,951)
38,591
66,599
7,373
(27,711)
46,261
71,874
11,818
(20,237)
63,455
102,297
(8,849)
(75,000)
18,448
83,812
(396)
(55,000)
28,417
99,904
2,574
(45,000)
57,479
40.7
35.9
1.1
1.0
2.7
26.4
16.7
37.6
30.1
1.3
1.1
3.0
22.7
13.9
35.8
28.8
0.7
0.5
2.1
16.5
12.3
39.2
40.8
0.5
0.3
1.3
20.5
14.1
38.4
31.1
0.4
0.2
1.0
13.0
12.1
36.9
30.3
0.3
0.1
0.5
13.5
13.1
Tata Steel
Exhibit 9: Tata Steel (consolidated), Profit model, balance sheet and cash flow model, March fiscal year-ends, 2008-2013E (Rs mn)
2008
2009
2010
2011E
2012E
2013E
1,315,336
177,824
4,759
(40,854)
(41,370)
100,359
63,351
(40,493)
123,218
(1,399)
1,682
123,500
110,441
112.0
1,473,293
181,277
2,657
(32,902)
(42,654)
108,378
(40,945)
(18,940)
48,492
409
607
49,509
61,750
62.6
1,023,931
80,427
11,859
(30,221)
(44,917)
17,147
(16,837)
(21,518)
(21,208)
(152)
1,269
(20,092)
(3,255)
(3.3)
1,128,398
153,843
8,962
(28,076)
(45,048)
89,680
20,700
(30,906)
79,474
400
507
80,381
65,270
64.4
1,204,467
175,421
2,408
(31,398)
(47,166)
99,264
(29,779)
69,485
360
761
70,606
70,606
69.7
1,232,243
202,586
3,063
(30,147)
(50,401)
125,100
(37,530)
87,570
324
761
88,655
88,655
87.5
287,015
24,545
590,973
339,163
8,327
1,250,022
331,187
88,476
180,500
33,675
42,319
572,309
1,556
1,250,022
217,700
17,094
653,732
313,109
8,949
1,210,583
364,175
88,880
153,649
64,111
61,484
477,229
1,055
1,210,583
230,208
16,541
531,004
309,639
8,841
1,096,232
365,252
92,706
145,418
54,178
67,878
370,800
1,096,232
352,325
17,645
476,004
319,895
8,441
1,174,309
375,204
134,706
145,418
54,685
43,818
420,477
1,174,309
413,839
18,141
461,004
336,049
8,081
1,237,113
416,148
134,206
145,418
55,447
41,635
444,259
1,237,113
493,402
18,767
446,004
342,270
7,757
1,308,198
525,157
44,206
145,418
56,208
84,266
452,943
1,308,198
117,771
(22,227)
(79,967)
15,578
116,077
2,254
(83,608)
34,723
25,583
46,465
(69,472)
2,577
114,669
(39,421)
(97,000)
(21,752)
114,740
(7,628)
(87,610)
19,501
135,534
(2,463)
(69,410)
63,661
13.5
10.4
2.1
1.9
3.0
51.0
14.6
12.3
9.4
3.0
2.6
3.1
24.5
9.9
7.9
3.5
2.3
1.9
5.5
(1.5)
(34.8)
13.6
9.6
1.4
1.2
2.7
22.4
12.1
14.6
10.6
1.1
1.0
2.3
18.4
13.1
16.4
12.4
0.9
0.7
1.7
19.5
14.6
10
SELL
Expensive despite recent correction. Reliance Power (RPWR) stock has corrected by
~35% in the past three months and is now trading at 1.9X FY2012E book. We,
however, maintain our negative stance on account of (1) lack of fuel security for gasbased capacities, (2) dilution of earnings (and valuation) due to merger with RNRL, and
(3) inferior profitability of UMPPs. Operating results in 3QFY11 were ahead of our
estimate on account of better-than-estimated availability. Reiterate SELL.
Company data and valuation summary
Reliance Power
Stock data
193-106
52-week range (Rs) (high,low)
Market Cap. (Rs bn)
290.7
Shareholding pattern (%)
Promoters
84.8
FIIs
3.8
MFs
0.3
Price performance (%)
1M
3M
12M
Absolute
(17.5) (33.4) (14.0)
Rel. to BSE-30
(14.8) (25.9) (24.5)
Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)
2011
2.9
0.1
42.5
11.5
8.0
3.0
220.5
5.2
0.0
2012E
4.0
38.4
30.7
41.9
11.1
15.9
48.0
6.6
0.0
2013E
2.5
(36.7)
48.4
121.5
7.0
43.7
18.8
4.0
0.0
For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
Utilities
Reliance Power
Net sales
Operating costs
Cost of fuel
Personnel costs
Other expenses
EBITDA
EBITDA margin (%)
Other income
Interest & finance charges
Depreciation
PBT
Provision for tax (net)
Net profit
Extraordinary
3QFY11
2,513
3QFY11E
2,108
3QFY10
(121)
(146)
(267)
2QFY11
1,687
(1,242)
(196)
(458)
617
25
1,038
(685)
(77)
892
544
1,436
(1,242)
(193)
(324)
348
17
2,912
(520)
(400)
2,341
(445)
1,896
1,792
(2)
1,523
(186)
1,336
(997)
(153)
(254)
282
17
3,437
(499)
(375)
2,845
(497)
2,348
25
(61)
17
19
12
719
55
3.7
1.7
0.9
690
53
3.3
1.8
0.8
3QFY11E
19
(% Chg.)
3QFY10
2QFY11
49
FY2010
207
FY2011E
11,530
(221)
(245)
(815)
(1,073)
(518)
8,227
(70)
(57)
7,026
(187)
6,839
(5,027)
(1,200)
(2,286)
3,016
26
8,961
(2,219)
(798)
8,960
(949)
8,011
17
17
(518)
3
26
11
545
42
3.3
1.8
0.7
149
69
1.4
1.5
7.1
2,989
66
3.9
1.7
1.2
77
(331)
119
(62)
(41)
(69)
(24)
(39)
(% Chg.)
5,463
2,175
390
181
(381)
28
17
Equity Investment
(Rs bn)
6.0
6.2
7.0
41.0
48.6
38.4
47.5
P/B
(X)
1.5
-0.2
5.2
1.0
1.0
1.9
3.5
1.9
RPWR's
share
100%
100%
74%
100%
100%
100%
100%
Value
(Rs bn)
9.2
-0.9
26.7
42.2
47.7
74.3
166.5
365.6
Cost of equity
(%)
12.5
12.5
12.5
12.5
12.5
15.0
15.0
Valuation
(Rs bn)
(Rs/share)
366
130
(200)
(71)
157
56
322
115
12
Reliance Power
Utilities
Project
Rosa II
Capacity
(MW)
600
Butibori
600
Land
Fuel
Enviroment
clearance
Financial
Closure
EPC
award
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
WIP
D
D
D
U
U
Sasan
3,960
WIP
Krishnapatnam
4,000
WIP
Chitrangi
3,960
WIP
Tilaya
4,000
WIP
Expected
CoD
Mar-12
Jun-12
Jun-13
Jul-15
Jul-14
Jun-17
13
Utilities
Reliance Power
Exhibit 5: Profit model, balance sheet, cash model of RPWR, March fiscal year-ends, 2009-2013E (Rs
mn)
2009
2010
2011E
2012E
2013E
(1,031)
3,604
(2)
2,570
(119)
2,445
2,445
1.1
207
(1,073)
8,227
(70)
(57)
7,026
(187)
6,839
6,839
2.9
11,530
3,016
8,961
(2,219)
(798)
8,960
(310)
(639)
1
8,011
8,011
2.9
41,890
15,918
10,125
(5,934)
(4,770)
15,339
(1,542)
(2,286)
(421)
11,090
11,090
4.0
121,541
43,734
5,085
(22,033)
(14,823)
11,963
(2,665)
(1,171)
(1,103)
7,024
7,024
2.5
Balance sheet
Paid-up common stock
Total shareholders' equity
Deferred taxation liability
Minority interest
Total borrowings
Total liabilities and equity
Net fixed assets
Capital work-in progress
Investments
Cash
Net current assets (excl. cash)
Net current assets (incl. cash)
Total assets
23,968
137,791
13,325
151,116
2,879
46,780
103,172
216
(1,931)
(1,715)
151,116
23,968
144,630
22,406
167,037
23,408
68,029
79,152
1,338
(4,890)
(3,552)
167,037
28,051
167,294
689
1,679
415,223
584,885
100,160
432,280
42,386
10,059
52,445
584,885
28,051
178,384
2,975
2,100
493,229
676,688
238,153
398,568
22,491
17,475
39,966
676,688
28,051
185,408
4,146
3,203
535,197
727,954
569,471
126,960
5,341
26,181
31,523
727,954
2,447
(4,065)
(39,351)
(40,969)
6,896
2,959
(41,835)
(31,979)
9,447
(14,950)
(441,801)
(447,303)
18,567
(7,416)
(109,051)
(97,900)
24,121
(8,706)
(74,533)
(59,118)
10
1.8
57.5
15
4.8
60.3
4.3
221
5.1
59.9
2.7
261
6.4
64.7
2.5
281
3.9
67.6
3.3
Profit model
Net revenues
EBITDA
Other income
Interest (expense)/income
Depreciation
Pretax profits
Tax
Deferred taxation
Minority interest
Net income
Extraordinary items
Reported profit
Earnings per share (Rs)
Ratios
Net debt/equity (%)
Return on equity (%)
Book value per share (Rs)
ROCE (%)
14
BUY
IVRCL (IVRC)
Construction
Revenue and EBITDA gains nullified by interest cost and depreciation. IVRCL
delivered reasonable revenues growth of 15% yoy in 3QFY11, however, higher interest
cost and depreciation led to flat PAT yoy. The management reduced FY2011 revenue
guidance to Rs62.5 bn (may still be aggressive as we build Rs58.2 bn). Debt and
working capital remain stable on a qoq basis, a partial tie up of equity for BOT assets
may help push execution as concession agreement, land, financial closure make
progress. Retain BUY as stock trades at 4X FY2012E P/E adj. for equity holdings.
Company data and valuation summary
IVRCL
Stock data
195-60
52-week range (Rs) (high,low)
Market Cap. (Rs bn)
19.2
Shareholding pattern (%)
Promoters
9.5
FIIs
57.7
MFs
7.9
Price performance (%)
1M
3M
12M
Absolute
(34.5) (48.4) (54.7)
Rel. to BSE-30
(32.1) (42.9) (59.8)
Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)
2011
7.0
(11.7)
10.3
58.3
1.9
5.5
7.0
9.6
0.6
2012E
8.9
28.1
8.0
72.7
2.4
6.9
6.0
11.2
0.6
2013E
12.6
40.7
5.7
92.5
3.4
8.8
4.9
13.9
0.6
Price (Rs): 72
Target price (Rs): 125
BSE-30: 18,202
QUICK NUMBERS
Revenues at Rs14.2
bn up 15% yoy
EBITDA margins
expands 90 bps yoy
to 9.9%
Net PAT at Rs423
mn flat yoy due to
interest cost (up
59% yoy) and
depreciation (up
43% yoy)
Revises full year guidance of Rs62.5 bn; we build in full year revenues of Rs58.2 bn
The management reduced the FY11 revenues guidance to Rs62.5 bn. The present guidance still
implies a strong growth of 35% in the last quarter. We believe this would be difficult to achieve
and have built in FY2011E revenues of Rs58.2 bn, implying yoy revenue growth of 18% in 4QFY11.
Equity for BOTs partly tied upmay scale up execution; IVRCL parent not to invest directly
Present portfolio of IVRCL Assets BOT projects requires incremental equity of about Rs13.5 bn.
Funds up to Rs6.5 bn are already tied up through (1) issue of compulsorily convertible debentures
of Rs2.5 bn to IFCI (2) Rs1.5 bn investment from UTI and (3) Rs2.5 bn NCDs. The rest are to be
funded from the stake sale of existing and upcoming BOT projects, land sales as well as equity
dilution in IVR Prime. IVRCL Infra. as a parent entity is not likely to invest in IVR Prime to fund the
equity of BOT projects.
Revise est. on back of higher interest cost; retain BUY on valuation, visibility and likely pick up
We have revised our FY2011E, FY2012E and FY2013E estimate to Rs7 (Rs7.7 earlier), Rs8.9
(Rs10.3 earlier) and Rs12.6 (Rs15.7) primarily based on higher interest cost versus earlier estimates.
We have revised our target price to Rs125 from Rs190 earlier based on (1) using 10X multiple now
versus 13X earlier, (2) lower valuation of listed subsidiaries (Rs20 impact) and (c) reduction in
earnings estimates. We retain our BUY rating as (1) execution of road projects may pick up as a
part of equity gets tied up, and agreements and financial closures are completed, (2) attractive
valuation 4X FY2012E P/E adjusted for equity holdings in IVR Prime and HDO, (3) order book
visibility.
For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
Construction
IVRCL
Net Sales
CoGS
Constrn, stores & spares
Subcontracting exp.
Masonry & labour
Staff cost
Other expenditure
Expenditure
EBITDA
Other income
PBIDT
Interest
Depreciation
Profit before tax
Tax
Profit after tax
3QFY11 3QFY11E
14,188
13,199
(11,769)
(5,325)
(1,894)
(4,551)
(604)
(411)
(12,784) (11,945)
1,404
1,254
11
54
1,415
1,308
(592)
(486)
(199)
(170)
625
653
(202)
(215)
423
437
3QFY10
12,347
(10,498)
(4,263)
(2,563)
(3,672)
(479)
(256)
(11,233)
1,115
39
1,153
(372)
(139)
643
(216)
427
2QFY11
10,750
(8,812)
(4,095)
(1,684)
(3,033)
(633)
(352)
(9,797)
953
57
1,010
(480)
(184)
345
(112)
233
Order book
Order backlog
Order booking
242,000
16,188
173,428
41,275
240,000
53,450
85.0
3.9
2.1
9.0
5.2
3.5
33.6
82.0
5.9
3.3
8.9
3.2
2.2
32.6
83.0
4.3
2.9
9.9
4.4
3.0
32.3
9.5
4.9
3.3
33.0
% change
yoy
14.9
12.1
24.9
(26.1)
23.9
26.1
60.6
7.0
13.8
12.0
26.0
(79.3)
(71.2)
8.2
22.7
21.8
59.0
17.2
43.3
(4.3)
(2.8)
(6.4)
(6.6)
(3.3)
(0.9)
vs est.
7.5
39.5
(60.8)
qoq
32.0
33.6
30.0
12.4
50.0
(4.6)
16.9
30.5
47.3
(80.2)
40.1
23.2
7.9
80.9
79.4
81.7
0.8
(69.7)
9MFY11
36,002
(29,703)
(13,026)
(5,479)
(11,198)
(1,888)
(1,045)
(32,637)
3,365
76
3,442
(1,525)
(540)
1,376
(440)
937
82.5
5.2
2.9
9.3
3.8
2.6
31.9
9MFY10
35,386
(30,158)
(13,311)
(7,271)
(9,576)
(1,299)
(673)
(32,130)
3,255
135
3,390
(1,115)
(401)
1,874
(608)
1,265
% change
1.7
(1.5)
(2.1)
(24.6)
16.9
45.3
55.4
1.6
3.4
(43.5)
1.5
36.8
34.7
(26.6)
(27.8)
(26.0)
#DIV/0!
#DIV/0!
85.2
3.7
1.9
9.2
5.3
3.6
32.5
Road projects execution slow as some projects may be just getting ready for
execution now
The slowdown in execution of the roads segment projects is reflected in the revenue
contribution of this segment (transportation segment) of 12% of the total 9MFY11 revenues
versus a backlog contribution of about 27%. We believe water resources and irrigation
segments have contributed their fair share to the revenues (equal revenue and backlog
contribution) while the buildings segment has recorded a strong revenue contribution of
about 24% versus a backlog contribution of 19%.
16
IVRCL
Construction
Segment wise break-up of IVRCL's order book and revenues for 1HFY11
9MFY11 revenues (Rs36 bn)
Water resources
46%
Electrical
4%
Buildings and
Industrial
19%
Transportation
27%
Buildings and
Industrial
24%
Transportation
12%
Recently signed concession agreements for two BOT projects; Goa still remaining
The company has signed concession agreements for two of the three recent BOT project
wins viz. (1) Rs15 bn Sion-Panvel expressway (won in Sept-2010- financial closure likely to
happen soon) and (2) Rs7.5 bn Karanji-Wani-Ghuggus-Chandrapur road (won in Sept-2010
financial closure likely to happen soon). The Rs31 bn Maharashtra-Goa project (won in
June-2010) is still awaiting concession agreement and financial closure.
Sion-Panvel and Karanji-Chadrapur concession agreements signed in 3QFY11
Key details of existing and recent BOT project wins of IVRCL
Sion-Panvel
Expressway
Concession agreement yet to be signed
25 kms of a 10-lane
concrete expressway from
Sion to Panvel
Project Description
Company's share
51%
Other partners
Kakade Infra.
Project Type
Concession Period
Construction period
Toll
30 years
2 years
Toll
23 years
3 years
Positive grant of
Rs6,647.2 mn
Toll
18 years and 9 months
Grant structure
No grant
Concession agreement
signed, financial closure
expected soon
Project status
Estimated Funding structure (in Rs mn)
Total project Cost
14,500
Equity
3,000
Debt
7,600
Grant
3,900
IVRCL's Equity Commitment
1,530
Rs2,318.4 mn VGF
Concession agreement
signed, financial closure
expected soon
7,500
1,295
3,886
2,318
1,295
Concession agreement to
be signed
31,000
7,170
6,647
2,318
7,170
17
Construction
IVRCL
Construction work has begun on several financially closed BOT projects including BaramatiPhaltan, Chengapalli- Walayar and Indore-Gujarat.
Key details of completed and financially closed BOT projects of IVRCL
JallandharAmristar
Completed/ Financially closed projects
4 laning of 49 km
JallandharProject Description
Amristar stretch
Company's share
100%
Other partners
Project Type
Concession Period
Construction period
Grant structure
Toll
17.5 years
2.5 years
Positive grant of
Rs 330 mn
Project status
Operational
Estimated Funding structure (in Rs mn)
Total project Cost
3,430
Equity
671
Debt
2,365
Grant
395
IVRCL's Equity
671
Salem Kumarapalayam
Kumarapalayam
Chenagmpalli
Chennai
Water
BaramatiPhaltan
47 km from
53 km from Salem Kumarapalayam to
to Kumarapalayam Chengapalli
100 MLD
100%
100%
75%
Befesa
IOCL-tankage
4-laning of 78 km
Baramati-Phaltan- Construction of
Shirwal
12 tanks
75%
37.5%
155 km Indore
to Gujarat/MP
border
100%
NA
6-lanning of 42
km ChengapalliWalayar stretch
100%
NA
Two part
Toll
tariff
20 years
3 years
Positive grant of Rs
1290 mn
Toll
25 years
Annuity - (Rs350
mn per month)
Toll
15 years
27 years
Positive grant of
Rs1,220 mn
No grant
Rs230 mn
revenue share
Operational
Operational
Operational
25-27%
construction
completed
65%
construction
completed
5,020
800
2,930
1,290
800
4,215
650
3,390
175
650
5,680
1,730
3,950
3,820
700
1,900
1,220
525
30,000
2,250
2,250 -Sponser
25,500 - Senior
844
15,200
3,800
11,400
3,800
Toll
20 years
2 years
Positive grant of Rs
175 mn
1,297
Toll
25 years
Rs360 mn
revenue share
11,250
4,250
7,000
4,250
Order inflows just keeping pace; current backlog and its execution holds the key
The company reported an order backlog of Rs242 bn at end- 3QFY11 leading to an order
booking of about Rs16 bn in this quarter. The order backlog provides a revenue visibility of
about 3.4 years based on forward four quarter revenues.
Order book visibility at about three years based on forward four quarter revenues
Order backlog, booking and visibility (X) of IVRCL Infrastructure, March fiscal year-ends, 2002-3QFY11
(Rs bn)
280
Visibility (RHS)
(years)
3.8
3Q11
2Q11
1Q11
4Q10
3Q10
2Q10
1Q10
4Q09
3Q09
2Q09
0.2
1Q09
40
4Q08
0.8
3Q08
80
2Q08
1.4
1Q08
120
FY07
2.0
FY06
160
FY05
2.6
FY04
200
FY03
3.2
FY02
240
(0.4)
18
IVRCL
Construction
Net Sales
Expenditure
EBITDA
Other income
Interest
Depreciation
PBT
Tax
PAT
Order book
Order booking
Key ratios (%)
EBITDA margin
PBT margin
Net PAT margin
Effective tax rate
9.3
3.8
2.6
31.9
NA
9.2
5.3
3.6
32.5
4QFY11E
22,262
(20,092)
2,170
60
(625)
(190)
1,415
(487)
928
4QFY10 % chg.
19,537
13.9
(17,480)
14.9
2,058
5.5
20
202.4
(523)
19.5
(142)
34.1
1,412
0.2
(569)
(14.4)
844
10.0
FY2011E
58,265
(52,730)
5,535
136
(2,150)
(730)
2,791
(927)
1,864
FY2010 % chg.
54,923
6.1
(49,610)
6.3
5,313
4.2
155
(12.0)
(1,639)
31.2
(543)
34.5
3,286
(15.1)
(1,177)
(21.3)
2,109
(11.6)
NA
98,501
103,556
98,501
9.7
6.4
4.2
34.4
10.5
7.2
4.3
40.3
9.5
4.8
3.2
33.2
9.7
6.0
3.8
35.8
NA
5.1
Needs Rs13.5 bn of equity funding for road projects; may sell equity stake in
BOT projects
Present portfolio of IVRCL Assets BOT projects requires incremental equity of about Rs13.5
bn. Delays/difficulties in raising this equity would potentially lead to lower construction
revenues and/or may put stress on the standalone balance sheet. Funds up to Rs6.5 bn are
already tied up through (1) issue of compulsorily convertible debentures of Rs2.5 bn to IFCI
and (2) investment from UTI for about Rs1.5 bn and (3) issue of NCDs for a total of about
Rs2.5 bn. The rest are to be funded from stake sale of existing and upcoming BOT projects,
land sales etc. IVRCL Infrastructure as a parent entity is not envisaged to invest in equity of
BOT projects help in IVR Prime.
19
Construction
IVRCL
Revenues
EBIDTA
EBITDA margin (%)
PAT
EPS (Rs)
yoy growth (%)
Revenus
EBITDA
PAT
EPS
New estimates
FY2011E
FY2012E
58,265
72,655
5,535
6,902
9.5
9.5
1,864
2,389
7.0
8.9
6.1
4.2
(11.7)
(11.7)
24.7
24.7
28.1
28.1
Old estimates
FY2011E
FY2012E
58,664
74,642
5,573
7,091
9.5
9.5
2,063
2,759
7.7
10.3
6.8
(42.4)
(2.3)
(2.3)
% revision
FY2011E
FY2012E
(0.7)
(2.7)
(0.7)
(2.7)
(9.6)
(9.6)
(13.4)
(13.4)
27.2
(38.0)
33.7
33.7
We retain BUY as (1) execution of road projects may pick up as part of equity gets tied up,
and agreements and financial closures are completed, (2) attractive valuation 4X FY2012E
P/E adjusted for equity holdings in IVR Prime and HDO, (3) order book visibility.
20
IVRCL
Construction
Key order booking and execution segmental assumptions for IVRCL (standalone), March fiscal
yearends,2008-13E (Rs mn)
IVRCL Construction
Orders received
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Segmental
Water resources and irrigation
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Transportation
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Buildings
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
Electrical
Orders received
Growth (%)
Revenues
Growth (%)
Order backlog - year end
Bill to book ratio
2008
2009
2010
2011E
2012E
2013E
87,967
36,622
59.5
122,415
31.8
63,229
48,819
33.3
136,825
31.7
136,175
56,000
14.7
217,000
27.3
103,556
58,265
4.0
262,292
21.7
101,252
72,655
24.7
290,889
23.2
116,340
92,542
27.4
314,688
26.5
58,272
181.1
17,824
52.0
75,728
27.7
44,209
(24.1)
25,874
45.2
94,063
26.4
39,937
(9.7)
26,000
0.5
108,000
22.8
39,937
25,594
(1.6)
122,343
20.0
39,937
32,020
25.1
130,260
22.5
45,927
15.0
38,306
19.6
137,881
25.0
440
(80.3)
6,933
115.3
11,157
38.8
1,583
259.9
6,346
(8.5)
6,394
53.1
53,606
7,000
10.3
53,000
32,164
(40.0)
8,635
23.4
76,528
25,731
20
13,409
55.3
88,850
21.1
12.5
15.0
29,591
15.0
23,320
73.9
95,121
22.5
25,410
445.9
6,935
77.4
28,015
31.2
12,304
(51.6)
10,252
47.8
30,067
30.0
15,933
29.5
11,000
7.3
35,000
28.9
17,526
10.0
14,661
33.3
37,866
33.5
20,155
15.0
15,582
6.3
42,439
32.5
23,178
15.0
17,559
12.7
48,058
32.5
3,845
(58.8)
4,930
20.2
7,515
46.9
5,132
33.5
6,346
28.7
6,301
63.0
12,700
147.5
5,000
(21.2)
14,000
39.5
11,430
(10.0)
6,900
38.0
18,529
35.0
11,430
8,485
23.0
21,473
35.0
13,144
15.0
9,816
15.7
24,802
35.0
Project/ Business
Value of core construction business
Value of Hindustan Dorr Oliver
Value of IVRCL Prime Developers Ltd
Total
Valuation
(Rs mn) Rs/ share
24,156
89
2,697
10
6,921
26
125
Valuation methodology
# P/E multiple of 10X FY2012E earnings
# Discount to market price
# Discount to market price
#
21
Construction
IVRCL
Profit model and balance sheet of IVRCL, March fiscal year-ends, 2007-13E (Rs mn)
2007
2008
2009
2010E
2011E
2012E
2013E
Income statement
Operating Income
Operating Expenses
EBITDA
Other Income
Interest & Finance charges
Depreciation
Profit Before Tax
Tax expense
PAT
EPS (Rs)
23,059
(19,497)
2,301
74
(308)
(216)
1,851
(436)
1,415
10.9
36,606
(30,965)
3,544
45
(407)
(328)
2,853
(749)
2,105
15.8
48,819
(41,772)
4,145
299
(1,233)
(473)
2,738
(478)
2,260
16.9
54,923
(46,281)
5,313
155
(1,637)
(543)
3,288
(1,177)
2,111
7.9
58,265
(49,525)
5,535
136
(2,150)
(730)
2,791
(927)
1,864
7.0
72,655
(61,975)
6,902
148
(2,611)
(863)
3,576
(1,187)
2,389
8.9
92,542
(78,938)
8,791
160
(2,913)
(1,007)
5,032
(1,671)
3,361
12.6
Balance sheet
Total share holders funds
Share Capital
Reserves & Surplus
Loan Funds
Working Capital Loan
Long term
Total Sources of Funds
Net fixed assets
Net block
Capital WIP
Investments
Net Current Assets (excl Cash)
Cash and Bank Balances
Total
13,217
259
12,918
5,561
2,864
1,580
18,834
2,435
1,929
506
2,829
11,332
2,238
18,834
16,060
267
15,789
10,678
5,215
5,159
26,841
3,733
3,192
541
3,409
17,928
1,772
26,841
18,106
267
17,839
13,980
7,645
3,949
32,203
5,403
5,207
196
3,892
21,900
1,009
32,203
18,533
534
17,999
16,133
9,103
3,489
34,791
6,017
5,664
353
6,138
20,992
1,644
34,791
20,276
534
19,742
22,883
22,542
43,159
6,684
6,434
250
5,910
27,381
3,184
43,159
22,544
534
22,010
24,883
24,542
47,427
7,321
7,071
250
6,210
30,989
2,907
47,427
25,784
534
25,250
27,383
27,042
53,168
8,064
7,814
250
6,210
35,139
3,755
53,168
(4,340)
1,851
216
308
(399)
(6,316)
(1,407)
(5,747)
(3,657)
2,853
328
407
(650)
(6,596)
(2,264)
(5,922)
22
2,738
473
1,233
(449)
(3,972)
(2,611)
(2,589)
5,213
3,288
543
1,637
(1,162)
908
(5,087)
127
(1,769)
2,791
730
2,150
(1,051)
(6,390)
(1,169)
(2,938)
2,255
3,576
863
2,611
(1,187)
(3,608)
(1,800)
455
3,131
5,032
1,007
2,913
(1,671)
(4,150)
(1,750)
1,381
10.0
6.1
0.4
0.3
15.7
10.7
9.7
5.7
0.7
0.6
14.4
10.4
8.5
4.6
0.8
0.7
13.2
10.5
9.7
3.8
0.9
0.8
11.5
9.6
9.5
3.2
1.1
1.0
9.6
8.5
9.5
3.3
1.1
1.0
11.2
9.1
9.5
3.6
1.1
0.9
13.9
10.6
Key ratios
EBITDA margin (%)
PAT margin (%)
Debt/ equity (X)
Net debt/ equity (X)
ROAE (%)
ROACE (%)
22
REDUCE
Disappointing quarter. While sales were in line, EBITDA margin at 15.4% was down
350 bps qoq and below our est. of 18% due to (1) steep margin dip in services business
and (2) sequential decline of around 150 bps in margin of products business (80% of
sales) which is perplexing, given (1) 7% qoq increase in its sales, (2) sequential
improvement in selling pricing and (3) adequate raw material inventory. We cut our
FY2011-12E est. by 16-30% to account for (1) acute margin pressure the business is
facing and (2) poor revenue generation (5% in 9MFY11 excl. one-time H1N1 business
last year) and (3) increase in interest cost on account of FCCB repayment in May 2011E.
We downgrade to REDUCE with PT of Rs220 (from Rs350), 13X FY2012E.
QUICK NUMBERS
Forecasts/Valuations
EPS (Rs)
EPS growth (%)
P/E (X)
Sales (Rs bn)
Net profits (Rs bn)
EBITDA (Rs bn)
EV/EBITDA (X)
ROE (%)
Div. Yield (%)
2010
26.5
49.0
7.3
37.8
4.5
8.3
6.6
26.3
1.0
2011E
14.6
(45.1)
13.3
34.5
2.6
5.8
10.1
11.9
1.0
2012E
16.9
15.9
11.4
38.7
2.7
7.0
8.2
12.1
1.3
We downgrade to
REDUCE with PT of
Rs220 (from Rs350),
13X FY2012E
3QFY11 revenues,
up 2% qoq, in line
with our estimate
EBITDA margin at
15% was lower
than our estimate
of 18% and down
360 bps qoq
EBITDA margin at 15% was lower than our estimate of 18% and down 350 bps qoq
EBITDA margin excluding other income was down 350 bps qoq to 15% on account of (1) negative
margin in services business in 3QFY11 versus 2.6% in 9MFY11 due to postponement of milestone
income and (2) lower margin in products business at 22.8% in 3QFY11 versus 23.3% in 9MFY11,
implying that pricing pressure in pyridine and chemicals business still remains. This is despite this
business witnessing (1) 7% qoq increase in sales, (2) sequential improvement in selling pricing and
(3) adequate raw material inventory.
We cut our FY2011-12E est. by 16-30%
We cut our FY2011-12E est. by 16-30% to account for (1) acute margin pressure faced by the
services business. Our analysis shows EBITDA margin in services business excl. high-margin contract
of H1N1 was 10-12% in 9MFY10 which has collapsed to 3% in 9MFY11. We believe steady state
margin of 16-18% outlined by Jubilant is contingent upon healthy revenue generation, which has
not been seen YTD, with DDDS facing sales dip of 20% in 9MFY11 and sequential decline in CMO
business in 3QFY11, (2) poor revenue generation (5% in 9MFY11 excl. one-time H1N1 business)
and (3) increase in interest cost on account of inc. in debt to repay FFCB in May 2011E.
We downgrade to REDUCE from BUY with PT of Rs220 (from Rs350), 13X FY2012E
We believe the key revenue drivers are some time away(1) new launches in APIs, the two major
sartans Jubilant has filed DMF for expire only in 2012E and (2) revenue generation from capacity in
pyridines is likely in 2HFY12-13E.
For private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
Pharmaceuticals
Net sales
Change in stock
Cost of trading goods sold
RM consumed
Stores, spares
Mfg exp
Staff cost
Selling exp
Exchange loss/(gain)
Total Expenditure
EBITDA
EBITDA, %
Other income
Interest
Depreciation
PBT
Tax
PAT
Minority interest
PAT before exceptional
Exceptional item
PAT
Lifescience ingredients
Generics
CMO
Drugs discovery & development
Hospitals
Total
3,102
549
710
1,790
870
(570)
6,450
2,200
25.4
100
390
310
1,600
200
1400
30
1,370
(420)
950
2QFY11
8,500
(95)
499
2,778
522
673
1,789
756
7
6,929
1,571
18.5
73
221
488
934
42
892
(5)
897
(7)
891
3QFY11E
1
NM
NM
(18)
11
2
(4)
23
NM
6
(17)
(3)
(58)
(5)
(1)
(36)
(17)
(39)
NM
(38)
NM
(41)
% change
3QFY10
0
NM
NM
(14)
4
(1)
(1)
(3)
NM
14
(41)
(10)
(58)
(27)
59
(65)
(46)
(68)
NM
(66)
NM
(54)
2QFY11
2
NM
46
(4)
9
4
(1)
11
NM
6
(17)
(4)
(43)
29
1
(40)
158
(49)
NM
(49)
NM
(50)
5,240
950
1,750
690
20
8,650
5,470
1,100
1,390
510
30
8,500
5
5
(17)
(1)
(17)
1
11
24
(34)
(29)
25
0
6
7
(17)
(4)
(17)
2
3QFY11
8,665
107
729
2,681
568
700
1,777
843
(35)
7,368
1,297
15.0
42
286
493
560
108
452
(8)
460
(19)
441
3QFY11E
8,553
3,250
513
684
1,850
684
6,982
1,571
18.4
100
300
500
871
131
740
(5)
745
745
3QFY10
8,650
5,820
1,180
1,150
490
25
8,665
5,517
1,121
1,391
493
30
8,553
LS Ingredients
Generics
Products
CMO
DDDS
Hospitals
Services
Total
Adjusted growth
9MFY10
15,630
2,820
18,450
9MFY11
16,600
3,270
19,870
%
6
16
8
FY2010
20,813
3,820
24,633
FY2011E
22,534
4,400
26,934
%
8
15
9
FY2012E
25,650
5,272
30,922
%
14
20
15
FY2013E
28,277
6,118
34,394
%
10
16
11
4,400
1,930
60
6,390
3,930
1,540
90
5,560
(11)
(20)
50
(13)
6,620
2,490
80
9,190
5,301
2,142
115
7,558
(20)
(14)
44
(18)
5,558
2,048
140
7,746
5
(4)
22
2
5,912
2,112
141
8,165
6
3
1
5
24,840
24,240
25,430
25,430
2
5
33,823
32,075
34,492
34,492
2
8
38,667
38,667
12
12
42,560
42,560
10
10
24
Pharmaceuticals
API
Esprosartan
Candesartan
Losartan
Valsartan
Olmesartan
Telmisartan
Irbesartan
Patent expiry
2014
Dec-12
4QFY11E
Sep-12
2016
2014
2011
Brand name
Teveten
Atancand
Hyzaar
Diovan
Benicar
Micardis
Avalide
Innovator
Abbott
Astrazeneca
Merck
Novartis
Daiichi
Boehringer
Sanofi
DMF filed
Y
Y
Y
Y
N
N
N
Genericised
N
N
Y
N
N
N
N
Source: US FDA
FCCB
Debt in standalone (Rupee)
Debt in standalone (FC)
Debt in Sub (Rupee)
Debt in Sub (FC)
Gross debt
Cash
Net debt
Net debt/Equity
Interest cost calculation
Interest bearing debt (Rupee)
Interest bearing debt (FC)
Total interest bearing debt
Average interest rate (Rupee)
Average interest rate (FC)
Interest cost
Interest cost in P&L
Interest cost (%)
FY2009
9,750
9,331
6,190
600
12,910
38,781
6,530
32,251
2.5
FY2010
8,610
6,800
4,710
510
10,570
31,200
7,601
23,599
1.1
Sep-10
6,390
3,990
7,750
510
10,070
28,710
1,410
27,300
1.2
Dec-10
6,350
5,880
7,600
260
9,700
29,790
980
28,810
1.4
FY2011E
6,350
6,019
7,600
260
9,700
29,929
1,690
28,238
1.3
FY2012E
10,354
7,600
260
9,700
27,914
500
27,414
1.2
9,931
19,100
29,031
7,310
15,280
22,590
10.6%
3.8%
1,558
1,505
5.8%
4,500
17,820
22,320
8.9%
4.2%
6,140
17,300
23,440
9.0%
4.2%
4.9%
5.0%
6,279
17,300
23,579
8.9%
4.2%
1,292
1,028
4.4%
10,614
17,300
27,914
10.0%
4.5%
1,626
1,600
6.2%
25
Pharmaceuticals
Profit and loss statement, March fiscal year-ends, 2008-2013E (Rs mn)
2008
2009
2010
2011E
2012E
2013E
Net sales
24,889 35,175 37,812 34,492 38,667 42,560
Operating expenses
Materials
(13,834) (18,461) (20,024) (15,713) (16,578) (17,927)
Selling and administration
(1,458) (1,805) (3,520) (5,979) (6,907) (7,180)
Employee cost
(3,670) (6,575) (7,453) (7,254) (8,342) (9,594)
R&D
(228)
(285)
Others
(1,420) (3,629)
1,070
50
Total expenditure
(20,382) (30,469) (29,926) (28,897) (31,827) (34,701)
EBITDA
4,507
4,706
7,886
5,595
6,840
7,858
Depreciation and amortisation
(1,039) (1,632) (1,247) (1,970) (2,200) (2,400)
EBIT
3,468
3,074
6,639
3,625
4,640
5,458
Net finance cost
(337) (1,070) (1,505) (1,028) (1,600) (1,800)
Other income
1,430
425
373
226
200
200
Pretax profits before extra-ordinaries
4,561
2,428
5,507
2,824
3,240
3,858
Current tax
(557)
(623)
(957)
(299)
(583)
(695)
Deferred tax
12
127
2008
Balance sheet
Net worth
Debt
Current liabilities
Deferred tax liabilities
Total equity and liabilities
Cash and cash equivalents
Current assets
Net assets incl CWIP
Investments
Total uses of funds
2011E
2012E
2013E
23,393
27,914
10,153
2,243
63,703
500
16,924
46,279
63,703
25,940
27,520
11,036
2,208
66,704
500
18,825
47,379
66,704
6,169
(160)
(3,500)
690
3,199
7,040
(1,205)
(3,500)
2,335
2009
4,218
1,553
(7,383)
(2,257)
(3,868)
2010
7,041
(752)
(2,011)
149
4,427
5,413
(2,157)
(3,704)
1,874
1,426
26
15-Feb-11
Price (Rs)
Rating
Mkt cap.
(Rs mn)
(US$ mn)
O/S
shares
(mn)
2010
EPS (Rs)
2011E
2012E
2012E
2010
PER (X)
2011E
2012E
EV/EBITDA (X)
2010
2011E 2012E
Price/BV (X)
2010 2011E 2012E
2010
RoE (%)
2011E
2012E
Target
price
Upside
(Rs)
(%)
ADVT-3mo
(US$ mn)
Automobiles
Ashok Leyland
Bajaj Auto
55
SELL
72,700
1,597
1,330
2.8
4.3
4.7
84.5
53.5
8.1
19.4
12.6
11.7
11.7
8.5
8.0
1.8
1.6
1.5
2.7
1.8
1.8
10.9
13.6
13.4
56
2.5
7.9
1,328
ADD
384,352
8,444
289
62.8
90.3
100.0
128.2
43.8
10.8
21.2
14.7
13.3
14.6
10.5
9.4
13.1
8.3
5.8
1.5
1.9
1.9
70.9
68.5
50.6
1,500
12.9
23.1
59.1
466.0
Bharat Forge
320
Hero Honda
1,517
668
239
0.7
12.4
19.7
(92.0)
1,705
11.3
7.7
4.9
3.6
3.0
6.1
8.5
16.4
405
26.4
4.1
REDUCE
ADD
302,945
6,655
200
111.8
97.8
109.8
73.9
(12.5)
12.3
13.6
15.5
13.8
8.2
9.5
8.0
8.4
6.3
4.8
2.0
2.0
2.0
59.0
45.0
39.5
1,485
(2.1)
34.0
BUY
410,891
76,593
9,027
1,683
615
35.1
42.8
47.7
133.6
22.1
11.6
19.1
15.6
25.8
14.0
16.2
13.4
23.9
10.9
9.6
5.1
3.8
3.1
1.3
1.4
1.5
30.0
27.6
24.5
800
19.8
35.9
Maruti Suzuki
1,237
BUY
357,295
7,849
289
86.4
78.4
91.8
105.0
(9.3)
17.0
14.3
15.8
13.5
7.5
8.0
6.6
3.0
2.5
2.1
0.5
0.4
0.5
23.3
17.4
17.3
1,460
18.1
9.8
Tata Motors
1,237
ADD
822,232
18,063
665
18.5
129.9
133.6
(141.1)
603.4
2.9
67.0
9.5
9.3
13.3
6.4
6.0
9.8
3.8
2.8
1.0
0.5
0.5
15.3
58.6
34.9
1,305
5.5
114.0
Automobiles
2,427,009
53,317
327.4
87.7
8.9
24.0
12.8
11.8
11.9
8.1
7.2
6.0
3.9
3.0
1.2
1.1
1.1
24.8
30.4
25.8
149
Cautious
BUY
72,168
1,585
485
21.6
25.9
28.0
60.1
20.2
8.2
6.9
5.7
5.3
1.6
1.4
1.1
3.4
4.0
4.4
26.0
25.8
23.4
190
27.7
4.7
1,275
BUY
516,516
11,347
405
62.1
81.7
99.9
22.7
31.6
22.3
20.5
15.6
12.8
3.2
2.8
2.4
0.9
1.2
1.5
19.2
19.1
20.1
1,600
25.5
58.3
83.7
108.0
Banks/Financial Institutions
Andhra Bank
Axis Bank
120.5
37.3
29.1
11.6
11.0
1.6
2.1
2.4
24.4
25.8
23.7
1,200
30.6
9.1
Bank of India
443
ADD
233,191
5,123
526
33.1
51.4
64.4
(42.1)
55.1
25.5
13.4
8.6
6.9
1.8
1.6
1.3
1.6
2.4
3.1
14.2
19.5
21.0
560
26.3
14.9
Canara Bank
Bank of Baroda
581
919
ADD
BUY
238,374
5,237
410
73.7
98.7
102.0
45.8
34.0
3.3
7.9
5.9
5.7
1.9
1.5
1.2
1.7
1.7
2.1
22.5
24.6
20.9
700
20.4
19.2
Corporation Bank
577
143
82.0
89.3
97.9
31.8
8.9
9.7
7.0
6.5
5.9
1.4
1.2
1.1
2.9
3.1
3.4
22.0
20.4
19.3
700
21.2
Federal Bank
385
ADD
65,839
1,446
171
27.2
34.3
44.5
(7.1)
26.3
29.7
14.2
11.2
8.6
1.4
1.3
1.2
1.3
1.6
2.1
10.3
11.9
14.0
450
16.9
5.9
HDFC
647
REDUCE
928,227
20,392
1,436
19.7
24.3
27.4
22.7
23.4
12.7
32.8
26.6
23.6
6.1
5.4
4.7
1.1
1.3
1.5
20.0
21.5
21.3
690
6.7
44.5
16.1
ADD
335,938
82,814
7,380
1,819
366
8.5
7.6
2.4
2.0
1.7
1.2
HDFC Bank
2,107
ADD
964,465
21,188
458
64.4
86.2
111.8
22.1
33.8
29.8
32.7
24.4
18.8
4.5
3.9
3.4
0.6
0.8
1.0
17.1
19.2
2,400
13.9
47.0
ICICI Bank
1,054
ADD
1,213,267
26,654
1,151
36.1
45.8
58.0
6.9
26.7
26.8
29.2
23.0
18.2
2.4
2.2
2.0
1.1
1.3
1.7
8.0
9.9
11.6
1,230
16.7
118.0
142
ADD
207,378
4,556
1,458
8.4
9.1
10.9
44.9
8.3
19.5
17.0
15.7
13.1
3.0
1.9
1.6
0.9
1.2
1.5
16.6
15.0
13.9
175
23.1
26.5
India Infoline
72
BUY
21,365
469
299
8.1
7.4
8.0
59.2
(9.0)
8.1
8.8
9.7
8.9
1.3
1.2
1.0
4.6
4.4
2.6
14.7
13.2
13.8
100
39.9
4.8
Indian Bank
218
ADD
93,883
2,062
430
35.1
37.9
43.5
25.5
8.1
14.6
6.2
5.8
5.0
1.4
1.2
1.0
3.0
3.1
3.6
24.1
21.7
21.0
320
46.5
2.9
131
BUY
71,505
1,571
545
13.0
17.6
24.1
(46.7)
35.3
37.1
10.1
7.5
5.5
1.1
1.0
0.9
2.7
2.9
3.2
9.6
12.1
14.9
180
37.1
J&K Bank
773
ADD
37,482
823
48
105.7
123.5
136.6
25.0
16.9
10.6
7.3
6.3
5.7
1.3
1.1
1.0
2.8
3.3
3.7
18.2
18.5
17.8
850
10.0
1.0
191
ADD
90,525
1,989
475
13.9
19.3
21.4
11.5
38.5
10.9
13.7
9.9
8.9
2.8
2.2
1.9
1.6
2.2
2.4
23.6
24.6
22.8
206
8.1
74.7
IDFC
345
ADD
86,549
1,901
251
64.9
25.3
30.5
9.8
7.6
5.8
5.3
1.2
1.0
0.9
2.6
3.4
3.8
14.5
16.9
16.4
450
30.3
8.7
262
REDUCE
300,773
6,607
1,148
20.5
24.1
28.2
54.0
17.5
17.0
12.8
10.9
9.3
2.4
2.0
1.8
1.7
1.8
2.2
19.0
19.3
19.5
300
14.5
4.1
BUY
345,240
7,584
315
123.9
138.2
166.1
26.4
11.5
20.3
8.8
7.9
6.6
2.1
1.7
1.4
2.0
2.6
3.1
26.2
23.9
24.0
1,500
37.0
9.7
ADD
118,600
2,605
246
13.1
6.6
17.0
(66.7)
(49.8)
159.7
36.8
73.4
28.3
1.7
1.7
1.6
1.3
0.5
1.4
5.0
2.3
5.9
600
24.5
26.3
20.8
1,095
482
45.3
59.1
3.6
243
REDUCE
239,491
5,261
987
20.3
25.5
29.2
23.2
25.9
14.5
12.0
9.5
8.3
2.2
1.9
1.6
2.7
3.2
3.6
22.0
21.2
21.2
275
13.4
Shriram Transport
712
ADD
158,842
3,490
223
39.2
55.8
65.9
30.1
42.5
18.1
18.2
12.8
10.8
4.3
3.6
3.0
1.7
2.4
2.8
28.4
29.3
28.7
800
12.4
7.3
SKS Microfinance
640
REDUCE
47,124
1,035
74
26.9
24.2
36.5
61.1
(10.3)
50.9
23.7
26.5
17.5
5.0
2.5
2.2
21.7
12.6
13.5
700
9.5
15.9
SREI
5,105
112
116
8.3
7.9
9.9
17.8
(4.8)
25.8
5.3
5.6
4.4
12.3
3.8
BUY
1,737,547
38,171
635
144.4
175.2
225.2
0.5
21.3
28.6
19.0
15.6
12.2
2.6
2.3
2.0
1.1
1.2
1.2
14.8
15.8
17.7
3,400
24.2
213.3
341
BUY
172,296
3,785
505
41.1
40.9
53.8
20.2
(0.4)
31.6
8.3
8.3
6.3
2.0
1.6
1.3
1.6
1.6
2.1
26.2
21.4
23.3
420
23.1
5.3
Yes Bank
277
340
15.0
21.4
26.4
370
33.5
23.0
44
Banks/Financial Institutions
BUY
Attractive
94,173
2,069
8,546,127
187,744
0.4
0.4
0.4
2.7
2.7
2.7
11.1
10.5
46.7
42.4
23.5
18.5
13.0
10.5
3.0
2.5
2.1
0.5
0.8
1.0
20.3
21.3
21.7
15.0
24.2
20.9
16.9
13.6
11.3
2.6
2.3
2.0
1.3
1.5
1.8
15.5
16.6
17.4
Cement
ACC
1,003
SELL
188,444
4,140
188
83.2
51.7
54.5
47.9
(37.9)
5.4
12.0
19.4
18.4
6.4
8.9
7.2
3.0
2.8
2.5
2.7
2.3
2.3
29.3
16.4
15.8
920
(8.3)
10.3
Ambuja Cements
119
SELL
181,467
3,987
1,522
8.0
7.9
7.9
11.4
(0.7)
(0.1)
14.9
15.0
15.0
8.2
7.9
7.0
2.6
2.3
2.1
1.6
1.7
1.9
19.3
16.8
15.0
108
(9.4)
4.9
Grasim Industries
2,309
ADD
211,671
4,650
92
301.0
224.3
261.1
26.1
(25.5)
16.4
7.7
10.3
8.8
4.6
5.3
4.1
1.7
1.5
1.3
1.4
1.5
1.5
22.9
15.4
15.7
2,600
12.6
India Cements
93
SELL
28,629
629
307
10.0
3.0
6.8
(43.5)
(70.5)
130.5
9.3
31.5
13.7
5.4
9.4
6.4
0.7
0.7
0.7
2.3
3.4
3.4
8.2
2.3
5.3
85
(8.8)
2.4
Shree Cement
1,641
REDUCE
57,161
1,256
35
208.0
84.0
161.7
19.0
(59.6)
92.6
7.9
19.5
10.1
3.9
6.7
3.7
3.1
2.8
2.3
0.6
0.6
0.6
48.0
15.2
25.0
1,680
2.4
0.6
946
REDUCE
259,226
5,695
274
88.2
42.3
79.7
1,030
8.9
6.9
Neutral
926,597
20,356
UltraTech Cement
Cement
12.0
(52.1)
88.6
10.7
22.4
11.9
12.5
10.0
5.8
4.8
2.2
1.8
0.3
0.4
0.4
25.9
11.9
19.3
19.3
(24.7)
31.2
12.1
16.0
12.2
6.4
7.4
5.4
2.5
2.0
1.7
1.4
1.4
1.4
20.6
12.3
14.2
3.3
NR
2,737
Union Bank
Rating
Mkt cap.
(Rs mn)
(US$ mn)
O/S
shares
(mn)
2010
EPS (Rs)
2011E
2012E
2012E
2010
PER (X)
2011E
2012E
EV/EBITDA (X)
2010
2011E 2012E
Price/BV (X)
2010 2011E 2012E
2010
RoE (%)
2011E
2012E
Target
price
(Rs)
Upside
(%)
ADVT-3mo
(US$ mn)
Consumer products
Asian Paints
Colgate-Palmolive (India)
Dabur India
GlaxoSmithkline Consumer (a)
2,588
ADD
248,231
5,453
96
71.5
82.6
100.4
85.3
15.5
21.5
36.2
31.3
25.8
22.3
19.6
15.9
15.5
12.3
9.9
1.0
1.4
1.7
51.8
44.9
43.5
3,000
15.9
5.7
822
SELL
111,786
2,456
136
31.1
31.0
36.0
44.2
(0.5)
16.2
26.4
26.5
22.8
21.6
19.8
17.2
34.3
29.6
25.6
2.4
2.8
3.3
156.1
119.7
120.3
800
(2.7)
2.8
93
ADD
160,309
3,522
1,731
2.9
3.2
3.8
28.1
11.7
17.9
32.0
28.6
24.3
24.1
19.8
16.5
16.9
11.7
9.1
1.1
1.2
1.4
57.4
49.0
42.7
110
18.8
5.0
2,088
ADD
87,822
1,929
42
55.4
71.9
84.1
23.6
29.8
17.1
37.7
29.1
24.8
21.2
18.3
15.7
9.8
9.2
7.5
0.9
2.4
1.3
27.9
32.4
33.0
2,400
14.9
1.0
366
ADD
118,580
2,605
324
11.3
13.6
17.1
69.5
20.0
26.1
32.3
26.9
21.4
25.6
19.1
14.9
12.3
6.6
6.1
1.1
0.9
0.9
44.6
31.9
29.6
440
20.1
1.9
Hindustan Unilever
273
SELL
595,928
13,092
2,182
9.4
17.5
2.8
2.9
3.4
250
(8.5)
ITC
157
ADD
1,201,900
26,404
7,651
5.3
6.5
7.8
22.6
22.8
19.0
29.6
24.1
20.3
17.9
15.3
12.7
8.1
6.8
5.9
3.2
1.7
2.4
29.2
32.1
32.4
185
17.8
28.6
Jubilant Foodworks
499
SELL
31,871
700
64
5.6
11.5
14.5
347.1
104.4
26.3
88.9
43.5
34.4
47.6
25.8
17.5
27.1
16.7
11.3
47.3
47.6
39.1
450
(9.8)
13.4
Jyothy Laboratories
231
ADD
17,687
389
77
11.0
11.4
13.7
99.6
3.8
19.4
20.9
20.2
16.9
16.7
13.1
10.5
4.3
2.5
2.3
1.9
1.6
2.1
14.8
12.8
14.6
270
16.9
0.5
Marico
126
ADD
77,301
1,698
612
4.4
5.0
5.6
32.9
12.2
12.8
28.4
25.3
22.4
19.4
17.8
14.9
11.6
8.5
6.5
0.5
0.7
0.8
48.9
39.2
33.3
140
10.8
11.4
(0.9)
2.2
17.9
29.0
28.4
24.0
19.8
20.5
17.4
23.1
20.1
71.1
75.9
77.8
15.7
2.3
REDUCE
327,057
7,185
96
74.4
88.4
108.0
27.0
18.8
22.1
45.6
38.4
31.4
30.2
25.8
21.3
56.3
43.9
33.9
1.4
1.8
2.2
136.0
128.5
121.8
3,100
(8.6)
2.4
96
ADD
59,212
1,301
618
6.1
5.2
5.9
14.5
(14.0)
14.2
15.8
18.4
16.1
7.5
8.1
7.3
1.2
1.2
1.1
2.1
1.8
2.1
10.2
8.4
9.1
110
14.9
2.9
Titan Industries
3,213
ADD
142,612
3,133
44
57.3
107.1
125.9
29.3
87.1
17.5
56.1
30.0
25.5
35.7
21.8
18.0
19.3
12.4
8.6
0.5
0.4
0.4
38.7
50.3
39.8
4,100
27.6
33.7
United Spirits
1,137
126
27.3
33.1
47.0
1,550
36.3
8.5
3,392
9.6
Consumer products
ADD
Cautious
142,857
3,138
3,323,151
73,004
49.9
21.5
41.9
41.7
34.3
24.2
16.1
15.0
12.3
3.8
3.4
3.0
0.2
0.2
0.3
9.8
10.5
13.3
24.8
17.4
19.7
32.2
27.4
22.9
20.0
17.7
14.7
10.0
8.3
7.2
2.1
1.8
2.1
31.0
30.2
31.3
Constructions
IVRCL
BUY
19,465
428
267
7.9
7.7
10.3
9.2
9.4
7.1
6.4
7.3
6.0
1.1
1.0
0.8
1.1
0.5
0.5
11.5
10.6
12.7
190
160.6
102
BUY
26,133
574
257
7.1
7.2
9.7
6.1
1.2
34.3
14.3
14.1
10.5
8.2
9.2
7.6
1.2
1.1
1.0
1.3
2.0
2.0
9.3
8.0
10.1
160
57.1
3.8
Punj Lloyd
73
REDUCE
24,620
541
340
(3.4)
1.3
8.5
(52.6)
(137.2)
567.0
(21.2)
56.9
8.5
17.3
8.4
5.9
0.8
0.8
0.7
0.2
0.1
1.0
(4.2)
1.4
9.0
90
24.1
11.1
Sadbhav Engineering
98
BUY
14,768
324
150
5.1
6.2
8.7
0.5
20.2
41.0
19.2
15.9
11.3
13.5
9.0
7.5
3.6
2.8
2.7
0.3
6.1
6.1
15.8
17.8
23.9
175
77.8
0.4
56.2
54.2
15.9
73
Construction
(6.6)
(2.3)
33.7
7.6
Attractive
84,986
1,867
79.0
24.8
16.1
9.0
10.2
8.4
6.5
1.1
1.1
1.0
0.8
1.8
2.1
4.5
6.6
10.8
Aban Offshore
586
BUY
25,488
560
44
106.6
104.6
107.6
10.0
(1.9)
2.9
5.5
5.6
5.4
7.8
6.5
6.4
1.1
1.2
1.0
0.6
0.6
0.7
24.3
26.1
20.4
815
39.1
Bharat Petroleum
604
BUY
218,334
4,796
362
57.6
52.9
49.5
224.5
(8.2)
(6.4)
10.5
11.4
12.2
6.1
6.3
6.5
1.6
1.4
1.3
2.3
2.7
2.7
14.6
12.4
10.7
740
22.5
11.2
Cairn india
322
RS
610,921
13,421
1,897
5.5
30.2
49.1
29.0
445.6
62.6
58.1
10.7
6.6
45.8
8.0
4.9
1.8
1.6
1.4
4.7
3.1
15.6
22.4
15.7
410
SELL
101,348
2,226
247
15.4
21.0
21.7
44.6
36.2
3.5
26.6
19.5
18.9
15.7
12.1
11.5
22.0
20.9
19.8
3.0
4.1
4.3
83.8
109.9
107.9
390
(4.8)
0.8
GAIL (India)
458
ADD
580,393
12,750
1,268
24.8
29.4
37.4
11.7
18.8
27.3
18.5
15.6
12.2
10.4
9.3
8.2
3.2
2.8
2.4
1.6
2.0
2.5
17.4
18.1
19.8
540
18.0
14.3
98
REDUCE
55,007
1,208
562
7.3
8.5
8.6
232.7
16.8
0.9
13.4
11.5
11.4
6.9
7.0
6.5
3.2
2.6
2.2
1.0
2.2
3.5
27.1
24.9
21.1
90
(8.0)
4.0
Energy
GSPL
Hindustan Petroleum
353
BUY
119,620
2,628
339
51.6
46.3
39.5
204.2
(10.3)
(14.7)
6.8
7.6
8.9
2.4
2.6
2.6
0.9
0.8
0.8
3.4
4.1
3.5
13.1
10.6
8.3
490
38.9
10.1
333
BUY
808,143
17,754
2,428
49.1
34.8
35.2
399.0
(29.2)
1.0
6.8
9.6
9.5
5.2
5.8
5.5
1.5
1.4
1.3
3.9
3.2
3.2
22.4
14.1
13.1
440
32.2
9.1
1,287
ADD
309,417
6,797
240
115.2
135.5
145.1
13.9
17.7
7.1
11.2
9.5
8.9
4.9
3.6
3.2
2.1
1.8
1.6
2.6
3.3
3.5
16.8
18.3
17.3
1,490
15.8
2.6
283
BUY
2,417,370
53,106
8,556
23.0
28.2
32.5
0.9
22.6
15.4
12.3
10.0
8.7
4.4
3.8
3.4
1.9
1.7
1.5
2.9
5.0
3.9
14.8
16.2
17.3
355
25.6
32.7
(22.0)
13.3
12.7
Oil India
Oil & Natural Gas Corporation
Petronet LNG
121
SELL
1,998
750
5.4
8.0
9.1
Reliance Industries
942
REDUCE
2,802,499
61,566
2,976
49.6
61.7
68.6
Neutral
8,139,477
178,811
Energy
90,938
19.7
105
(13.4)
6.1
24.2
11.2
19.0
15.3
13.7
9.7
7.4
6.3
1.9
1.7
1.5
0.7
0.9
1.1
11.4
12.9
12.9
990
5.1
125.6
34.7
18.1
15.0
13.5
11.5
10.0
6.8
5.7
4.9
1.9
1.7
1.5
1.9
2.6
2.7
13.8
14.8
15.2
190.2
(1.8)
48.9
13.8
22.5
15.1
9.1
8.4
3.6
3.0
2.6
1.4
2.1
2.5
15.9
20.4
Industrials
31.4
(35.2)
(35.4)
21.1
22.5
31.9
11.9
5.8
5.4
4.4
0.3
0.5
0.5
15.6
9.2
23.2
725
9.4
1.6
515
REDUCE
37,105
815
72
28.0
40.9
46.4
74.6
46.3
13.4
18.4
12.6
11.1
10.4
7.8
6.7
5.3
4.0
3.1
1.4
1.6
1.8
31.8
36.0
31.6
600
16.4
8.1
Bharat Electronics
ABB
1,685
REDUCE
134,832
2,962
80
96.1
105.6
120.1
(7.4)
9.9
13.7
17.5
16.0
14.0
8.1
7.1
5.9
3.0
2.6
2.3
1.1
1.5
1.5
17.5
17.6
17.6
1,800
6.8
1.6
2,071
REDUCE
1,013,600
140.1
Crompton Greaves
Larsen & Toubro
663
REDUCE
140,400
3,084
212
16.7
10.8
37.7
22,267
490
87.9
115.5
267
BUY
171,024
3,757
642
12.8
14.4
16.2
46.5
12.0
12.5
20.8
18.5
16.5
12.0
10.6
8.9
6.8
5.2
4.1
0.5
0.7
0.8
37.9
31.9
27.8
310
16.3
7.1
ADD
983,299
21,601
605
57.9
74.9
86.0
15.6
29.2
14.9
28.0
21.7
18.9
16.0
11.8
10.2
4.4
3.6
3.1
0.8
0.7
0.9
18.6
18.4
17.7
1,850
13.9
66.1
23.6
17.9
14.8
12.9
10.1
8.2
6.4
5.0
4.0
0.9
1.2
1.4
29.8
31.3
30.2
2,400
15.9
32.8
Maharashtra Seamless
350
ADD
24,675
542
71
38.6
44.2
39.3
(10.9)
9.1
7.9
8.9
4.7
3.7
3.9
1.1
1.0
0.9
1.7
2.3
2.2
14.8
12.8
10.5
418
19.5
Siemens
838
REDUCE
282,591
6,208
337
22.4
27.4
33.2
39.5
21.9
21.3
37.4
30.6
25.3
20.0
18.3
14.8
8.7
7.2
5.9
0.6
0.7
0.8
25.2
25.6
25.5
735
(12.3)
9.5
48
REDUCE
76,419
1,679
1,594
(6.2)
(3.7)
3.5
(185.4)
(40.3)
(196.0)
(7.8)
(13.0)
13.6
13.6
17.0
7.5
1.1
1.1
1.1
0.4
(11.4)
(8.6)
7.9
45
(6.2)
25.9
Thermax
633
BUY
75,410
1,657
119
21.9
32.7
38.4
(9.6)
49.1
17.6
28.9
19.4
16.5
14.5
10.2
8.5
7.0
5.6
4.6
0.8
1.5
1.7
25.2
32.2
30.7
805
27.2
1.5
Voltas
177
331
10.9
10.6
12.1
57.4
200
13.1
4.5
Suzlon Energy
REDUCE
58,474
1,285
Cautious
2,997,829
65,857
Infrastructure
REDUCE
143,095
3,144
130
66.9
78.1
GMR Infrastructure
42
ADD
154,948
3,404
3,667
0.4
0.2
0.1
Container Corporation
56
BUY
23,613
519
424
(3.7)
(1.3)
1.1
1,101
60.5
29
BUY
45,481
999
1,579
1.0
1.3
1.5
IRB Infrastructure
175
BUY
58,047
1,275
332
11.6
13.5
12.3
142
2,017
3.3
4.2
6.7
Infrastructure
BUY
285,772
6,278
Cautious
710,956
15,619
28
Industrials
0.9
14.3
21.3
61.3
1,625
7.7
31.4
39.6
(2.1)
31.1
13.9
16.3
16.6
14.6
9.5
8.8
7.4
5.3
4.4
3.7
1.1
1.8
2.1
37.8
29.0
27.5
28.9
28.3
21.6
16.8
14.1
11.5
9.2
4.8
4.0
3.4
0.8
1.0
1.1
16.8
18.4
20.0
19.4
16.6
0.4
(0.6)
10.6
18.2
16.4
14.1
12.4
10.7
8.9
3.3
2.9
2.5
1.3
1.4
1.6
18.7
19.0
1,300
18.1
1.3
(43.7)
(49.4)
(55.8)
97.8
193.2
437.5
22.0
12.3
11.6
1.8
1.4
1.4
2.4
1.2
0.5
60
42.0
4.4
28.6
(64.8)
(186.1)
(15.0)
(42.8)
49.7
66.0
26.0
15.3
7.6
3.1
2.9
(75.1)
(9.7)
8.5
68
22.0
0.7
29.4
27.3
18.1
29.2
22.9
19.4
19.0
14.1
13.8
1.4
1.4
1.3
1.0
1.0
5.7
6.1
6.9
42
45.8
5.1
119.2
16.3
(8.8)
15.1
12.9
14.2
10.2
8.3
7.5
2.7
2.1
1.6
1.1
19.4
18.1
12.9
270
54.6
7.1
160
13.0
3.8
55.7
24.5
61.4
42.4
34.1
21.1
32.0
22.5
15.6
8.1
6.8
5.3
0.6
20.8
21.6
28.3
20.1
16.5
30.0
34.8
29.9
23.0
20.2
13.9
11.7
3.3
2.6
2.4
0.6
0.3
0.4
9.3
8.8
10.4
Company
15-Feb-11
Price (Rs)
Rating
Mkt cap.
(Rs mn)
(US$ mn)
O/S
shares
(mn)
2010
EPS (Rs)
2011E
2012E
2012E
2010
PER (X)
2011E
2012E
EV/EBITDA (X)
2010
2011E 2012E
Price/BV (X)
2010 2011E 2012E
2010
RoE (%)
2011E
2012E
Target
price
(Rs)
Upside
(%)
ADVT-3mo
(US$ mn)
Media
DB Corp
239
BUY
43,388
953
182
10.6
12.6
14.0
286.5
18.8
10.8
22.5
18.9
17.1
12.5
10.6
9.7
6.7
5.5
4.7
0.8
1.7
2.5
40.3
31.8
29.7
325
36.1
0.3
64
ADD
67,656
1,486
1,062
(2.5)
(1.6)
0.2
(63.1)
(33.2)
(109.5)
(25.8)
(38.6)
408.3
74.4
30.8
14.8
16.9
30.1
28.0
234.3
(56.0)
7.1
66
3.6
5.2
155
ADD
11,356
249
73
2.5
7.9
10.0
NM
220.4
27.5
63.1
19.7
15.5
17.6
12.8
10.4
3.2
2.6
2.2
4.8
4.8
6.5
17.9
23.7
16.4
200
29.2
0.0
HT Media
145
ADD
34,134
750
235
6.1
7.0
8.5
623.3
15.4
21.0
23.8
20.6
17.0
12.3
9.3
7.5
3.4
2.5
2.3
0.2
1.4
2.8
15.3
13.8
13.9
170
17.0
0.3
Jagran Prakashan
117
BUY
35,295
775
301
5.8
7.0
7.9
92.0
19.2
13.4
20.1
16.8
14.8
12.0
9.8
8.8
5.8
5.2
4.7
3.0
3.4
4.3
30.0
32.4
33.4
155
32.3
0.5
DishTV
Hindustan Media Ventures
Sun TV Network
405
117
Media
3,510
394
13.1
18.3
22.7
ADD
114,420
2,514
978
5.3
4.8
6.2
Cautious
REDUCE
466,027
159,780
10,238
44.0
26.3
195.8
35.5
450
11.0
5.5
28.4
21.9
24.3
18.9
17.9
15.2
11.7
2.9
2.8
2.7
0.9
1.1
1.2
12.7
11.8
14.7
130
11.2
7.6
36.1
39.7
35.9
37.8
27.8
20.4
18.2
13.6
10.6
5.4
4.7
4.3
1.2
1.4
1.9
14.2
16.8
21.0
(9.7)
24.1
31.0
22.2
17.9
17.6
12.8
10.4
8.3
6.9
5.8
1.8
1.8
2.5
28.3
34.2
302
ADD
1,910,384
41,968
6,316
15.2
21.1
363.0
13.0
22.6
19.9
17.6
14.3
11.9
9.3
8.1
7.0
5.6
4.5
1.2
1.7
2.1
40.4
35.4
34.8
345
14.1
212
ADD
406,534
8,931
1,914
20.0
16.2
16.9
25.0
(18.8)
4.3
10.6
13.1
12.6
6.1
7.4
7.5
1.9
1.7
1.5
0.6
0.6
0.6
20.4
13.6
12.7
250
17.7
49.7
1,269
BUY
536,151
11,778
423
95.6
103.7
125.5
48.2
8.4
21.0
13.3
12.2
10.1
9.0
7.4
4.9
2.8
2.3
1.9
0.5
0.5
0.5
25.1
21.7
21.5
1,535
21.0
4.9
931
38.2
41.0
48.0
16.9
7.1
17.3
17.0
15.9
13.5
11.8
10.8
8.9
5.4
4.0
3.1
0.2
0.4
0.4
37.7
29.2
26.0
640
(1.7)
24.5
37.4
651
REDUCE
606,001
13,313
JSW Steel
898
17.2
REDUCE
222,929
4,897
248
80.4
67.1
99.2
481.1
(16.5)
47.9
11.2
13.4
9.1
9.2
8.1
5.4
2.0
1.3
1.0
0.8
1.0
1.1
16.0
11.6
12.1
1,000
11.3
405
SELL
261,042
5,735
644
12.2
18.3
20.5
(37.2)
50.5
12.0
33.3
22.1
19.7
15.5
10.3
8.8
2.5
2.3
2.1
0.6
1.2
1.2
7.8
10.9
11.3
300
(26.0)
Sesa Goa
309
REDUCE
274,607
6,033
890
29.6
52.6
62.2
23.5
77.9
18.3
10.4
5.9
5.0
8.6
3.6
4.8
3.4
2.0
1.5
1.2
1.2
1.2
35.8
32.9
33.0
315
2.1
25.9
Sterlite Industries
164
BUY
549,631
12,074
3,362
12.0
13.0
19.4
2.8
8.0
49.4
13.6
12.6
8.4
8.7
7.2
4.4
1.5
1.3
1.2
0.6
0.6
0.6
12.9
11.2
14.8
200
22.3
26.2
Tata Steel
617
624,790
13,726
1,013
(3.3)
64.4
69.7
(103.6)
(2,051.8)
8.2
(186.8)
22.4
18.4
710
15.1
107.3
5,392,068
118,455
18.9
19.0
BUY
Attractive
9.4
36.3
21.3
18.1
9.6
8.8
11.9
6.5
5.9
2.7
1.8
1.5
1.1
1.2
13.3
10.9
10.0
7.8
6.5
3.2
2.5
2.1
0.8
1.1
1.1
(1.5)
17.7
0.6
Pharmaceutical
19.0
28.8
35.7
42.2
32.9
24.3
20.4
11.5
3.5
3.3
2.9
8.3
10.4
12.1
565
22.3
Biocon
336
ADD
67,230
1,477
200
14.8
18.3
22.7
216.4
23.4
24.2
22.7
18.4
14.8
13.1
9.9
8.2
3.8
3.2
2.7
17.9
19.3
20.5
445
32.4
5.5
Cipla
Apollo Hospitals
310
REDUCE
248,785
5,465
803
13.7
12.1
16.0
38.1
(11.9)
32.3
22.6
25.7
19.4
16.2
17.2
13.3
4.2
3.7
3.2
0.6
0.8
0.8
21.1
15.4
17.9
300
(3.2)
14.0
Cadila Healthcare
769
ADD
157,370
3,457
205
24.7
33.3
38.2
66.9
34.9
14.7
31.1
23.1
20.1
20.1
15.8
13.5
9.7
7.2
5.7
0.7
0.9
1.0
36.0
35.9
31.6
880
14.5
1.7
102
ADD
8,284
182
81
14.4
15.8
20.7
(19.7)
9.7
30.7
7.1
6.4
4.9
6.7
6.0
4.6
1.0
0.9
0.8
15.5
15.1
17.0
210
106.2
Divi's Laboratories
462
BUY
59,472
1,307
129
10.9
14.0
28.2
14.5
1.6
0.7
656
REDUCE
87,022
1,912
133
25.8
26.8
37.1
(19.2)
3.9
38.6
25.5
24.5
17.7
18.8
18.2
12.4
5.7
5.0
4.2
24.7
21.7
25.6
700
6.7
2.4
Dr Reddy's Laboratories
1,539
REDUCE
261,346
5,741
170
48.0
68.4
72.2
48.1
42.6
5.5
32.1
22.5
21.3
17.7
12.8
11.9
6.9
5.4
4.5
0.7
0.5
0.6
22.2
27.0
22.9
1,150
(25.3)
15.0
18.4
15.9
10.5
29.7
2,000
(10.0)
2,222
REDUCE
188,236
4,135
85
59.1
70.2
79.6
8.1
18.7
13.5
37.6
27.9
21.8
Glenmark Pharmaceuticals
285
REDUCE
79,671
1,750
280
12.7
17.6
20.6
14.3
38.3
17.3
22.4
16.2
13.8
14.5
10.9
9.7
3.4
2.8
2.4
16.4
18.4
18.2
330
16.0
5.9
193
REDUCE
30,753
676
159
26.5
14.6
16.9
49.0
(45.1)
15.9
7.3
13.3
11.4
6.6
10.1
8.3
1.4
1.4
1.3
1.0
1.0
1.3
26.3
11.9
12.1
220
14.0
1.3
Lupin
423
ADD
188,086
4,132
445
15.3
17.6
22.4
27.3
15.0
26.9
27.6
24.0
18.9
23.1
19.8
15.4
7.3
5.9
4.7
0.7
0.8
1.1
34.1
27.3
28.0
465
9.9
15.1
Ranbaxy Laboratories
516
234.8
(39.4)
Sun Pharmaceuticals
424
SELL
ADD
Cautious
221,119
71.9
21.5
35.4
17.7
11.5
18.1
5.6
9.0
4.1
7.7
3.7
0.8
0.8
29.8
7.0
30.7
20.1
1.3
4,858
428
7.2
24.0
14.6
(128.9)
10.4
340
(34.1)
11.2
438,939
9,643
1,036
13.0
17.4
19.7
(25.7)
33.4
13.1
32.5
24.4
21.5
25.8
18.3
15.0
5.5
4.6
3.8
0.6
0.6
0.6
18.2
21.0
19.9
480
13.2
10.3
2,124,912
46,681
45.3
20.0
12.8
28.8
24.0
21.3
17.9
14.3
12.5
5.4
3.6
3.1
0.5
0.6
0.6
18.6
14.8
14.4
22.6
23.9
17.4
17.6
15.0
Property
DLF
240
ADD
410,940
9,028
1,714
10.6
10.0
13.8
12.4
1.4
1.3
1.2
0.9
1.2
2.1
6.6
5.5
7.3
265
10.6
46.5
149
ADD
62,022
1,363
415
15.9
23.0
28.4
(24.4)
44.0
23.9
9.4
6.5
5.3
7.5
7.6
4.6
0.9
0.7
0.6
10.0
11.8
12.5
180
20.4
29.6
115
RS
46,277
1,017
402
(0.4)
3.1
8.5
(134.9)
(60.1)
(865.5)
(5.5)
178.9
37.3
(288.9)
37.7
13.5
(45.9)
52.3
15.5
0.4
0.4
0.4
(0.2)
1.0
2.9
21.4
343
BUY
13,987
307
41
19.2
21.7
30.4
69.7
13.1
40.1
17.9
15.8
11.3
16.0
13.2
7.8
1.5
1.4
1.2
1.0
1.2
1.3
8.6
9.0
11.6
435
26.9
0.4
Oberoi Realty
228
BUY
75,084
1,649
330
13.7
18.7
24.9
57.1
36.9
32.7
16.6
12.2
9.2
14.6
7.9
5.1
4.0
2.2
1.8
0.1
0.4
0.7
27.7
23.3
21.5
305
33.9
1.0
Phoenix Mills
186
BUY
26,941
592
145
4.1
6.1
7.6
(16.7)
48.6
24.2
45.0
30.3
24.4
37.7
22.7
17.4
1.8
1.7
1.6
0.6
0.8
1.1
3.9
5.7
6.7
300
61.3
Puravankara Projects
105
REDUCE
22,506
494
213
6.8
7.3
8.8
0.6
7.6
19.9
15.5
14.4
12.0
18.0
16.3
11.7
1.6
1.5
1.3
1.9
1.9
1.9
10.5
10.5
11.6
100
(5.2)
0.1
Sobha Developers
242
BUY
23,682
520
98
14.1
18.8
24.0
(7.1)
33.4
27.9
17.2
12.9
10.1
14.3
10.7
8.2
1.4
1.2
1.1
0.4
0.5
0.7
9.7
10.1
11.7
380
57.3
1.7
35
RS
93,187
2,047
2,666
3.0
2.4
3.9
(58.8)
(21.3)
62.1
11.5
14.6
9.0
14.4
16.2
9.1
0.9
0.8
0.7
0.9
9.0
5.6
8.3
(100.0)
41.0
774,627
17,017
(44.6)
15.3
42.0
19.7
17.1
12.0
16.1
13.7
9.7
1.2
1.0
1.0
0.7
0.8
1.3
5.9
6.1
8.1
Unitech
Property
Cautious
0.3
Pharmaceuticals
31.7
Rating
Mkt cap.
(Rs mn)
(US$ mn)
O/S
shares
(mn)
2010
EPS (Rs)
2011E
2012E
2012E
2010
PER (X)
2011E
2012E
EV/EBITDA (X)
2010
2011E 2012E
Price/BV (X)
2010 2011E 2012E
2010
RoE (%)
2011E
2012E
Target
price
(Rs)
Upside
(%)
ADVT-3mo
(US$ mn)
Sugar
Bajaj Hindustan
78
SELL
14,849
326
191
(7.9)
0.2
6.4
(343.6)
(102.5)
3,238.8
(9.9)
402.4
12.1
10.1
6.2
4.5
0.7
0.7
0.7
0.9
0.9
0.9
(7.1)
0.2
5.8
80
3.1
72
ADD
18,563
408
257
0.8
8.3
8.4
(89.9)
974.0
1.0
93.3
8.7
8.6
12.3
5.4
4.3
1.4
1.2
1.1
0.6
0.6
0.6
1.5
14.8
13.1
90
24.5
4.6
3.9
83
REDUCE
55,727
1,224
670
8.8
4.4
4.2
164.5
(49.8)
(4.2)
9.4
18.8
19.6
6.0
8.9
8.2
2.2
1.8
1.5
0.5
0.4
0.4
29.1
11.4
9.8
90
8.2
25.0
10.7
Cautious
89,140
1,958
(4.2)
11.6
21.3
19.3
17.3
14.3
8.0
7.0
5.7
1.5
1.3
1.2
0.6
0.5
0.5
7.7
7.7
8.2
HCL Technologies
483
REDUCE
338,100
7,428
700
17.5
22.8
29.6
0.2
30.3
29.4
27.6
21.2
16.3
13.6
12.8
10.1
4.8
4.3
3.7
0.8
1.6
1.7
19.3
21.7
24.5
440
(8.9)
Hexaware Technologies
107
BUY
15,428
339
144
9.3
5.1
10.4
127.7
(45.6)
104.3
11.5
21.1
10.3
6.2
13.9
7.0
1.8
1.7
1.5
0.9
0.9
0.9
17.8
8.2
15.0
125
16.4
BUY
1,783,160
39,173
574
108.3
120.0
155.2
5.7
10.8
29.3
28.7
25.9
20.0
21.1
18.0
13.8
7.7
6.9
5.6
0.8
1.9
1.5
30.1
28.1
30.9
3,700
19.1
74.5
76,028
1,670
1,176
2.5
3.1
4.3
(190.7)
24.7
37.4
26.0
20.9
15.2
12.0
11.9
7.1
4.0
3.6
3.4
58.5
18.5
23.2
70
8.3
15.4
0.7
Sugar
Technology
Infosys Technologies
Mahindra Satyam
Mindtree
3,107
65
REDUCE
6.1
449
REDUCE
18,471
406
41
52.2
27.1
41.5
294.3
(48.1)
53.1
8.6
16.6
10.8
7.4
8.8
5.6
2.8
2.4
2.0
0.5
0.6
0.9
35.2
15.4
19.9
500
11.4
Mphasis BFL
664
SELL
139,983
3,075
211
43.6
51.8
48.9
207.6
18.8
(5.5)
15.2
12.8
13.6
12.3
11.0
9.5
6.0
4.2
3.3
0.5
0.6
0.7
48.1
38.6
27.4
610
(8.2)
189
SELL
18,833
414
100
15.4
19.5
19.5
16.9
26.8
0.3
12.3
9.7
9.7
6.2
7.8
6.5
2.2
1.8
1.6
1.9
2.0
2.1
18.6
20.5
17.7
175
(7.4)
4.6
1,098
BUY
2,148,418
47,197
1,957
35.1
44.4
54.0
32.8
26.4
21.6
31.3
24.7
20.3
23.9
18.3
14.2
10.3
8.4
6.9
1.8
1.6
2.0
37.6
37.4
37.2
1,350
23.0
43.6
TCS
Tech Mahindra
636
Wipro
425
Technology
1,730
124
65.1
65.1
65.9
ADD
1,040,934
22,868
2,447
18.9
21.7
25.6
Attractive
REDUCE
5,734,798
78,763
125,984
(9.6)
(0.1)
1.3
9.8
9.8
9.6
8.0
8.7
8.1
2.7
2.2
1.9
0.5
0.3
0.3
34.5
26.3
5.9
22.1
720
13.3
3.2
22.1
15.2
17.7
22.6
19.6
16.7
17.1
14.3
11.6
5.3
4.4
3.6
0.8
1.0
1.3
26.5
24.4
23.7
525
23.4
18.1
24.6
17.4
21.1
26.0
22.1
18.3
18.7
15.9
12.5
6.8
5.8
4.8
1.2
1.7
1.6
26.1
26.3
26.3
24.4
14.3
38.1
Telecom
329
REDUCE
1,249,980
27,460
3,798
5.8
(27.7)
24.6
13.9
19.3
15.5
7.9
9.3
7.4
3.0
2.6
2.2
15.3
305
(7.3)
IDEA
62
REDUCE
204,588
4,494
3,300
2.7
2.4
1.2
(5.8)
(11.2)
(48.9)
22.7
25.5
50.0
8.0
9.0
7.8
1.8
1.7
1.6
7.2
6.9
3.5
55
(11.3)
MTNL
Bharti Airtel
44
SELL
27,815
611
630
(15.6)
(10.4)
(9.1)
(750.8)
(33.7)
(11.9)
(2.8)
(4.3)
(4.8)
1.0
1.2
1.6
0.3
0.3
0.3
(8.5)
(6.1)
(5.7)
35
(20.7)
1.3
Reliance Communications
102
SELL
216,557
4,757
2,133
19.7
6.9
7.9
(30.9)
(65.2)
15.0
5.1
14.8
12.9
6.5
8.2
7.4
0.5
0.5
0.5
0.8
11.0
3.3
3.7
90
(11.4)
23.9
Tata Communications
211
285
14.0
15.2
15.7
225
6.8
0.9
Telecom
REDUCE
60,021
1,319
Cautious
1,758,961
38,641
5,847
23.6
17.1
21.3
3.2
8.2
3.5
15.0
13.9
13.4
6.2
5.7
5.4
0.8
0.8
0.8
3.1
3.6
4.0
5.2
5.5
5.5
(12.3)
(38.9)
17.9
12.6
20.6
17.5
7.7
9.1
7.4
1.5
1.4
1.3
0.2
0.1
0.1
12.1
6.9
7.6
NM
155.8
7.6
Utilities
Adani Power
122
CESC
ADD
266,178
2,180
0.8
2.8
16.5
252.0
500.1
44.3
7.4
130.6
31.5
6.7
4.6
4.2
2.7
44.1
140
295
BUY
36,825
809
125
34.6
36.6
42.7
8.5
5.8
16.8
8.5
8.1
6.9
5.3
4.9
5.7
0.9
0.8
0.7
1.5
1.6
1.8
10.8
10.2
10.8
459
55.7
1.3
Lanco Infratech
40
BUY
96,441
2,119
2,405
2.1
3.6
4.9
46.6
67.4
36.6
18.8
11.2
8.2
12.2
8.5
6.5
2.9
2.3
1.8
17.4
21.0
22.5
80
99.5
8.6
NHPC
24
REDUCE
299,523
6,580
12,301
1.9
1.5
1.7
74.9
(19.4)
15.6
13.1
16.3
14.1
9.1
9.8
7.8
1.2
1.1
1.1
2.3
1.6
1.9
9.7
7.1
7.8
28
15.0
4.4
NTPC
181
REDUCE
1,491,605
32,768
8,245
10.5
10.1
11.9
6.8
(3.2)
17.6
17.2
17.8
15.2
2.0
2.1
1.9
2.3
14.1
12.6
13.7
195
7.8
Reliance Infrastructure
635
BUY
169,803
3,730
267
62.0
60.8
70.8
(1.0)
(1.9)
16.3
10.2
10.4
9.0
10.4
7.3
6.0
0.8
0.7
0.7
1.0
1.5
1.6
6.5
9.1
10.7
1,030
62.2
31.7
Reliance Power
121
SELL
340,256
7,475
2,805
2.9
2.9
4.0
179.7
0.1
38.4
42.5
42.5
30.7
(336.7)
237.0
51.1
2.4
2.1
2.0
4.8
5.2
6.6
115
(5.2)
12.7
1,269
ADD
313,146
6,879
247
63.5
70.7
84.4
26.7
11.3
19.4
20.0
17.9
15.0
12.3
12.4
11.6
2.4
2.2
2.0
0.9
1.1
1.2
13.8
13.0
14.0
1,415
11.5
7.1
3,013,776
66,208
22.6
3.6
37.2
19.2
18.6
13.5
14.5
14.5
10.9
2.0
1.8
1.7
1.4
1.3
1.5
10.4
9.9
12.3
Tata Power
Utilities
Cautious
13.2
13.4
12.1
2.3
2.2
4.2
9.9
14.7
4.0
11.8
Others
Havells India
Jaiprakash Associates
332
ADD
41,463
911
125
6.1
23.2
28.9
141.3
278.2
24.5
54.1
14.3
11.5
15.5
9.8
7.8
9.7
6.0
4.1
0.6
0.8
0.8
14.3
52.1
42.4
425
27.9
1.7
85
BUY
187,444
4,118
2,214
1.7
5.1
5.6
(12.7)
188.8
11.6
48.4
16.8
15.0
21.6
12.5
11.0
2.2
1.9
1.7
5.1
12.2
12.1
135
59.5
30.5
(71.7)
Jet Airways
488
BUY
42,129
926
86
(69.8)
25.6
58.7
(136.7)
129.5
(7.0)
19.1
8.3
12.4
7.8
6.4
2.4
2.2
1.7
12.0
23.0
850
74.2
19.8
Sintex
166
REDUCE
45,043
990
272
12.1
14.4
16.5
(49.6)
19.3
14.5
13.7
11.5
10.0
11.9
9.1
7.7
2.1
1.8
1.5
0.7
0.8
0.8
15.5
15.7
15.3
180
8.7
7.0
44
BUY
17,893
393
403
2.5
5.2
6.1
(117.4)
104.4
16.8
17.5
8.6
7.3
20.5
4.2
5.5
(5.2)
4.2
2.7
(15.9)
516.3
44.8
85
91.4
4.2
Tata Chemicals
320
REDUCE
77,951
1,712
243
26.4
26.8
35.4
(27.1)
1.5
31.9
12.1
11.9
9.1
6.4
5.7
4.3
1.7
1.5
1.3
2.8
3.0
3.0
16.0
16.9
19.3
370
15.5
3.9
United Phosphorus
143
BUY
1,456
462
11.9
12.9
17.6
220
53.5
6.9
SpiceJet
18.1
8.3
37.3
12.1
11.1
8.1
6.6
5.7
4.3
2.2
1.7
1.5
1.3
1.4
1.4
19.1
17.5
19.4
478,198
10,505
(539.8)
140.7
29.0
33.1
13.7
10.7
13.0
9.2
7.9
2.4
2.0
1.7
0.8
0.8
0.8
7.2
14.2
15.7
46,988,639
1,032,264
21.1
20.2
20.6
19.0
15.8
13.1
11.2
9.5
8.0
2.9
2.5
2.2
1.3
1.5
1.6
15.3
15.7
16.5
38,849,162
853,453
17.3
20.9
22.3
20.7
17.1
14.0
13.5
11.5
9.4
3.3
2.7
2.4
1.1
1.3
1.4
15.8
16.0
17.0
32,530,496
714,642
19.0
20.2
22.2
21.7
18.0
14.8
15.2
13.0
10.5
3.3
2.8
2.5
1.2
1.3
1.4
15.3
15.7
16.7
Others
KS universe (b)
66,274
Notes:
(b) 2010 means calendar year 2009, similarly for 2011 and 2012 for these particular companies.
(c) EV/Sales & EV/EBITDA for KS universe excludes Banking Sector.
(d) Rupee-US Dollar exchange rate (Rs/US$)=
45.52
30
Company
Disclosures
70%
60%
50%
40%
32.1%
33.3%
5.1%
5.1%
ADD
REDUCE
30%
23.1%
20%
11.5%
10%
3.2%
0.6%
0%
BUY
SELL
Other definitions
Coverage view. The coverage view represents each analysts overall fundamental outlook on the Sector. The coverage view will consist of one of the following
designations: Attractive, Neutral, Cautious.
Other ratings/identifiers
NR = Not Rated. The investment rating and target price, if any, have been suspended temporarily. Such suspension is in compliance with applicable
regulation(s) and/or Kotak Securities policies in circumstances when Kotak Securities or its affiliates is acting in an advisory capacity in a merger or strategic
transaction involving this company and in certain other circumstances.
CS = Coverage Suspended. Kotak Securities has suspended coverage of this company.
NC = Not Covered. Kotak Securities does not cover this company.
RS = Rating Suspended. Kotak Securities Research has suspended the investment rating and price target, if any, for this stock, because there is not a sufficient
fundamental basis for determining an investment rating or target. The previous investment rating and price target, if any, are no longer in effect for this stock
and should not be relied upon.
NA = Not Available or Not Applicable. The information is not available for display or is not applicable.
NM = Not Meaningful. The information is not meaningful and is therefore excluded.
31
Corporate Office
Overseas Offices
London EC 3N 1 LS
Tel: +91-22-6634-1100
Tel:+1-914-997-6120
Copyright 2011 Kotak Institutional Equities (Kotak Securities Limited). All rights reserved.
1.
Note that the research analysts contributing to this report may not be registered/qualified as research analysts with FINRA; and
2.
Such research analysts may not be associated persons of Kotak Mahindra Inc and therefore, may not be subject to NASD Rule 2711 restrictions on
communications with a subject company, public appearances and trading securities held by a research analyst account.
Kotak Securities Limited and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We along with
our affiliates are leading underwriter of securities and participants in virtually all securities trading markets in India. We and our affiliates have investment banking
and other business relationships with a significant percentage of the companies covered by our Investment Research Department. Our research professionals
provide important input into our investment banking and other business selection processes. Investors should assume that Kotak Securities Limited and/or its
affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research
professionals who were involved in preparing this material may participate in the solicitation of such business. Our research professionals are paid in part based on
the profitability of Kotak Securities Limited, which include earnings from investment banking and other business. Kotak Securities Limited generally prohibits its
analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that
the analysts cover. Additionally, Kotak Securities Limited generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or
advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals may provide oral or written market commentary
or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may
make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of
the foregoing, among other things, may give rise to real or potential conflicts of interest. Additionally, other important information regarding our relationships with
the company or companies that are the subject of this material is provided herein.
This material should not be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would
be illegal. We are not soliciting any action based on this material. It is for the general information of clients of Kotak Securities Limited. It does not constitute a
personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice
or recommendation in this material, clients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The
price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any
investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Kotak Securities
Limited does not provide tax advise to its clients, and all investors are strongly advised to consult with their tax advisers regarding any potential investment.
Certain transactions -including those involving futures, options, and other derivatives as well as non-investment-grade securities - give rise to substantial risk and are
not suitable for all investors. The material is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should
not be relied on as such. Opinions expressed are our current opinions as of the date appearing on this material only. We endeavor to update on a reasonable basis
the information discussed in this material, but regulatory, compliance, or other reasons may prevent us from doing so. We and our affiliates, officers, directors, and
employees, including persons involved in the preparation or issuance of this material, may from time to time have long or short positions in, act as principal in,
and buy or sell the securities or derivatives thereof of companies mentioned herein. For the purpose of calculating whether Kotak Securities Limited and its affiliates
holds beneficially owns or controls, including the right to vote for directors, 1% of more of the equity shares of the subject issuer of a research report, the holdings
does not include accounts managed by Kotak Mahindra Mutual Fund. Kotak Securities Limited and its non US affiliates may, to the extent permissible under
applicable laws, have acted on or used this research to the extent that it relates to non US issuers, prior to or immediately following its publication. Foreign currency
denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the
investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies affectively assume currency risk. In addition
options involve risks and are not suitable for all investors. Please ensure that you have read and understood the current derivatives risk disclosure document before
entering into any derivative transactions.
This report has not been prepared by Kotak Mahindra Inc. (KMInc). However KMInc has reviewed the report and, in so far as it includes current or historical
information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. Any reference to Kotak Securities Limited shall also be
deemed to mean and include Kotak Mahindra Inc.